rfhg_143582.1

Basic information about the TSS

---

TSS ID: rfhg_143582.1 Species: human Chr: chr11		Start: 117192580 End: 117192588 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000525478.5:-1 GeneID: 51092 HGNC/MGI_ID: HGNC:24272 UniProt_ID: H0YEI3 Nearer transcript ids and distances: LF376533:14 MA612110:14 ENST00000532062.1:29 LF376532:231 MA612109:231 LF376534:-278 MA612111:-278 view more...

Gene_name: SID1 transmembrane family member 2 Gene_symbol: SIDT2 Gene_synonyms: CGI-40 Gene_source: HGNC:24272

TATA-Box annotation

---

Distance to TSS:	-6710
Nearest PromoterID:	NM_001001522
Entrez ID:	6876
Nearest Unigene:	Hs.410977
Nearest Refseq:	NM_003186
Nearest Ensembl:	ENSG00000149591
Gene Name:	SID1 transmembrane family member 2
Gene Alias:	SM22|SM22-alpha|SMCC|TAGLN1|WS3-10
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.555556
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SIDT2 p2@SIDT2 p3@SIDT2 p4@SIDT2 p5@SIDT2 p6@SIDT2 p7@SIDT2 p8@SIDT2 p9@SIDT2 p10@SIDT2
Sample		p1@SIDT2	p2@SIDT2	p3@SIDT2	p4@SIDT2	p5@SIDT2	p6@SIDT2	p7@SIDT2	p8@SIDT2	p9@SIDT2	p10@SIDT2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	4.48	3.31	0.19	0.58	0.78	0.39	0.00	0.00	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	2.83	5.66	0.20	1.01	0.61	0.00	0.00	0.00	0.20	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	3.09	4.82	0.39	1.16	0.39	0.39	0.00	0.00	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	2.08	3.33	0.00	1.04	0.42	0.00	0.00	0.00	0.00	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	2.70	2.02	0.45	1.35	0.90	0.45	0.00	0.45	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	3.49	2.91	0.00	0.19	0.39	0.39	0.00	0.00	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	4.58	3.70	0.22	0.65	0.87	0.87	0.00	0.00	0.44	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	2.66	4.12	0.24	2.18	0.73	0.00	0.00	0.00	0.48	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	4.70	5.98	0.21	1.50	0.43	0.21	0.00	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	6.38	6.38	0.00	2.90	2.32	1.16	0.00	0.58	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	9.70	4.04	1.21	3.64	2.83	0.81	0.00	0.00	0.81	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	6.50	5.29	0.41	2.03	1.63	1.63	0.00	0.41	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	6.13	6.29	0.64	0.81	1.61	0.64	0.00	0.32	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	3.46	6.01	0.75	0.75	1.20	0.60	0.00	0.30	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	4.39	7.25	0.66	0.66	0.88	1.98	0.00	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	6.04	5.78	0.75	1.01	0.25	0.75	0.00	0.25	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	4.37	7.43	0.66	0.66	0.66	0.22	0.00	0.87	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	4.22	6.33	0.42	0.42	0.84	0.84	0.00	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	4.27	8.00	0.00	0.53	1.07	2.13	0.00	0.53	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	4.96	5.57	0.90	1.05	1.20	0.60	0.00	0.30	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	4.95	5.21	0.53	1.34	1.20	0.40	0.00	0.27	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	4.83	4.14	0.52	0.86	1.55	0.69	0.00	0.52	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	4.65	5.04	1.03	0.39	0.65	0.65	0.13	0.13	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	2.91	6.55	0.24	0.49	1.46	0.49	0.00	0.49	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	5.93	8.51	0.26	1.03	1.03	0.52	0.00	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	4.11	7.28	0.63	0.95	0.32	0.32	0.00	0.00	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	4.40	8.24	0.55	0.55	2.75	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	6.37	4.72	0.94	0.71	0.71	0.47	0.00	0.47	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	3.88	5.33	0.32	0.48	1.45	0.32	0.00	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	3.98	5.79	1.63	1.09	1.99	0.18	0.00	0.18	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.65	5.23	0.00	0.21	0.84	1.05	0.00	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	5.28	5.86	1.56	0.59	1.17	0.78	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	4.64	8.44	0.21	1.90	1.48	0.00	0.00	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	3.30	4.29	1.15	0.66	0.82	0.66	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	5.42	5.05	0.75	0.75	1.50	0.93	0.00	0.19	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	5.56	5.17	0.57	1.72	1.15	0.19	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	4.09	6.34	1.23	0.82	0.20	0.61	0.00	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	5.04	3.63	0.60	0.60	0.60	0.40	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	6.21	5.94	0.54	0.81	0.81	1.08	0.00	0.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	4.32	5.04	0.24	0.48	1.20	0.72	0.00	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	3.53	4.71	0.71	0.71	0.00	0.24	0.00	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	3.22	1.76	0.15	0.59	0.59	0.44	0.00	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	4.43	3.59	0.84	0.42	0.63	0.42	0.00	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	4.72	5.24	0.87	0.70	1.22	0.17	0.00	0.00	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	6.42	5.02	0.40	0.40	0.80	1.81	0.00	0.00	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	3.95	5.35	0.70	0.70	0.23	1.63	0.00	0.23	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	3.12	3.12	0.72	0.96	1.20	0.48	0.00	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	3.58	6.56	0.00	2.09	0.60	0.30	0.00	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	3.83	7.66	0.72	0.24	0.00	0.00	0.00	0.24	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	5.66	4.04	0.20	0.61	1.62	0.20	0.00	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.61	5.33	0.20	0.82	0.61	0.61	0.00	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	4.89	6.67	0.22	1.33	0.89	0.67	0.00	0.89	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.03	3.90	0.35	0.35	0.00	0.71	0.00	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	5.30	4.31	0.00	0.66	0.00	0.66	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	5.03	1.68	0.00	0.84	0.00	0.84	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	2.76	1.38	0.00	0.46	0.46	0.00	0.00	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	5.51	5.19	0.32	0.00	0.65	0.65	0.00	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	5.14	2.25	0.32	0.64	0.32	0.32	0.00	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.54	4.71	0.00	0.63	1.26	0.63	0.00	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	4.23	2.82	0.00	0.00	0.00	1.41	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	3.93	1.12	1.12	0.56	0.00	0.56	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	5.57	10.35	0.00	0.00	1.59	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	6.12	2.04	0.68	0.00	0.00	0.68	0.00	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	6.82	5.52	0.32	0.00	0.97	0.32	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	5.32	2.48	0.71	1.42	1.06	0.35	0.00	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	3.41	2.93	0.00	0.00	0.49	0.00	0.00	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	4.96	0.99	0.50	0.00	0.50	0.99	0.00	0.50	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.57	4.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	6.62	2.98	0.66	0.33	0.00	0.00	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	4.64	2.78	0.62	0.62	0.31	0.93	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	5.20	2.14	0.31	0.31	0.61	0.00	0.00	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	20.91	13.15	0.79	2.06	0.95	2.85	0.00	0.48	2.22	0.00
Adipocyte - breast, donor2	11327-117E4	34.97	9.30	2.57	1.93	0.96	3.85	0.00	0.32	0.64	0.16
Adipocyte - omental, donor1	11473-119C6	32.95	15.65	1.40	2.67	1.91	3.94	0.00	0.64	3.18	0.38
Adipocyte - omental, donor2	11474-119C7	27.66	8.97	0.00	2.99	0.75	2.24	0.00	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	33.16	12.06	1.67	4.02	1.67	1.67	0.00	0.00	4.69	1.34
Adipocyte - perirenal, donor1	11476-119C9	28.07	10.85	0.64	1.91	1.28	1.28	0.00	0.00	2.55	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	19.79	2.20	0.00	1.10	0.00	0.00	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.90	2.71	0.90	0.45	0.45	1.81	0.00	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	36.49	5.56	2.09	0.87	1.04	1.91	0.00	1.04	0.87	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	20.73	11.34	1.37	1.96	0.98	1.37	0.00	0.00	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	18.27	9.27	0.51	1.54	1.54	2.06	0.26	0.00	0.77	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	17.84	4.74	1.12	1.67	1.39	1.12	0.00	0.84	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	31.74	6.47	1.76	0.00	1.18	1.76	0.00	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	16.73	6.35	0.56	1.29	0.72	1.29	0.00	0.40	0.48	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	23.24	5.81	0.32	0.97	1.29	0.97	0.00	0.97	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	19.73	4.80	0.53	0.00	0.53	2.13	0.00	0.53	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	28.38	5.56	0.56	0.56	1.67	1.67	0.00	0.56	1.67	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	33.27	3.74	0.42	1.25	0.42	2.50	0.00	0.83	2.08	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	33.91	6.03	1.00	1.51	1.76	2.01	0.00	1.00	0.25	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	25.85	7.53	1.31	1.64	1.64	1.64	0.00	0.65	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	28.01	2.74	0.91	0.00	0.61	1.52	0.00	1.22	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	9.72	6.19	1.99	0.88	0.88	0.22	0.00	1.33	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	9.32	8.61	0.72	1.43	1.08	0.36	0.00	0.72	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	3.59	0.00	0.00	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	4.50	5.40	0.90	0.54	0.90	0.18	0.00	0.00	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	10.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.57	8.01	0.82	1.44	1.23	0.21	0.00	0.41	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	10.18	16.48	1.37	2.17	1.49	0.34	0.00	0.46	0.23	0.57
Anulus Pulposus Cell, donor2	11463-119B5	20.33	15.18	1.71	1.71	2.20	0.49	0.00	0.24	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.93	4.04	0.90	2.25	0.90	0.00	0.00	0.00	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	13.46	9.55	2.17	1.30	1.74	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	4.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	15.54	8.67	0.60	1.20	1.20	0.60	0.00	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	11.38	10.12	0.00	0.00	1.26	0.00	0.00	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	7.92	0.66	0.66	0.00	0.66	0.00	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	8.77	6.50	0.32	0.97	0.32	0.00	0.32	0.00	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	13.11	7.77	0.49	1.46	0.97	0.00	0.00	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	4.16	0.59	1.19	0.59	0.59	0.00	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	10.55	6.03	1.13	0.38	0.75	0.38	0.00	0.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	11.61	5.08	0.73	1.45	1.45	0.00	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	3.76	1.25	0.00	0.00	0.00	0.00	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	6.42	5.44	0.99	2.14	1.65	0.49	0.00	0.16	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	4.09	0.00	0.00	1.36	1.36	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.52	2.87	0.45	0.60	1.21	0.30	0.00	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.54	2.68	2.14	0.54	1.07	0.00	0.00	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	11.34	5.86	0.76	0.94	0.94	0.00	0.00	0.38	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.55	6.15	2.14	0.00	0.80	0.27	0.00	0.00	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	15.61	8.78	0.00	0.98	0.00	0.98	0.00	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	10.45	7.13	0.17	1.16	1.16	0.00	0.00	0.50	0.50	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	8.41	0.00	0.00	0.00	0.00	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	17.70	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.81	5.49	0.51	1.03	1.03	0.17	0.00	0.17	0.17	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.62	2.91	0.49	1.46	0.49	0.00	0.00	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	8.73	6.07	0.38	1.90	1.52	0.38	0.00	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	7.27	1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.41	5.13	0.57	1.71	1.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.90	9.62	0.43	1.28	0.64	1.07	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	7.23	8.00	1.03	0.77	2.32	0.00	0.00	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.79	7.04	0.94	1.88	1.41	0.47	0.00	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.93	5.14	0.32	1.29	1.29	0.96	0.00	0.32	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	4.99	0.71	1.43	0.71	0.71	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.19	8.19	0.00	0.00	1.17	0.00	0.00	0.00	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.73	7.53	0.60	0.30	0.00	0.00	0.00	0.90	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	4.75	0.00	1.19	1.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	12.71	5.09	1.53	0.51	0.51	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.40	5.60	0.76	0.25	0.51	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.99	3.81	1.27	0.00	0.64	0.00	0.00	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.93	8.20	0.43	0.43	0.86	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.83	6.35	0.64	1.27	0.85	0.00	0.00	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.44	4.93	0.29	1.16	0.29	0.00	0.00	0.29	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	7.56	7.56	1.89	0.94	1.89	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.80	3.90	0.51	1.02	0.85	0.00	0.00	0.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	4.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	6.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.72	4.72	0.21	0.64	0.21	0.43	0.00	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.82	5.41	0.60	1.80	0.00	1.20	0.00	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	8.75	0.73	0.73	2.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	11.26	5.06	1.15	1.38	0.46	0.69	0.00	0.23	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	7.65	5.10	0.00	0.00	2.55	0.00	2.55	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.64	2.80	1.02	1.02	0.25	0.25	0.00	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	15.48	7.02	0.00	1.45	1.45	0.41	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.02	5.81	0.92	1.84	1.22	0.61	0.00	0.00	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.73	5.26	1.91	0.48	0.48	0.48	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	8.65	7.54	0.44	0.67	1.11	0.22	0.00	0.44	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	7.63	1.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.86	9.42	1.11	1.66	2.22	0.00	0.00	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.80	5.56	0.26	0.79	0.79	0.26	0.00	0.53	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.45	5.82	0.00	1.09	0.73	0.36	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	20.14	16.70	2.33	2.95	2.33	0.49	0.00	1.23	0.37	0.49
Astrocyte - cerebellum, donor2	11580-120F5	15.40	11.13	1.20	2.74	1.20	0.51	0.00	0.34	0.17	0.34
Astrocyte - cerebellum, donor3	11661-122F5	19.72	13.42	1.68	3.36	3.57	0.21	0.00	0.84	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	2.79	9.76	1.05	2.09	0.00	0.00	0.00	0.35	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	3.40	8.57	0.65	1.13	1.29	0.16	0.00	0.16	0.00	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	4.77	6.56	0.45	1.49	0.45	0.00	0.00	0.00	0.30	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	13.53	4.82	1.49	0.69	1.26	0.69	0.11	0.57	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	12.65	3.76	1.63	0.25	1.50	0.38	0.38	0.38	0.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	10.13	3.64	2.05	0.23	0.57	0.23	0.00	0.46	0.11	0.00
Basophils, donor1	12241-129G9	27.98	2.62	1.31	0.52	0.00	1.05	0.00	0.26	0.00	0.00
Basophils, donor2	12242-129H1	19.48	5.05	1.08	0.72	1.08	1.44	11.18	0.36	1.08	0.00
Basophils, donor3	12243-129H2	37.48	10.00	2.79	2.06	1.91	0.88	10.14	0.29	0.59	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	11.21	6.47	1.51	0.00	0.43	0.65	0.00	0.43	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	9.14	10.97	1.83	1.37	1.37	0.91	0.00	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	5.65	5.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	3.95	4.57	0.83	0.21	0.62	0.21	0.00	0.21	0.21	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	3.45	4.38	0.46	0.46	0.00	0.00	0.00	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	6.30	5.58	0.72	0.36	0.72	0.36	0.00	0.54	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4.43	2.47	0.31	0.41	0.31	0.00	0.00	0.72	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	12.58	17.93	3.26	2.10	1.40	0.00	0.00	0.00	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	6.08	3.52	0.32	0.32	0.64	0.32	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	28.18	5.07	2.25	2.82	0.56	1.13	2.25	1.69	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	34.89	6.87	1.86	0.56	1.48	2.04	2.41	0.37	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	22.83	3.73	1.76	0.44	1.54	1.54	0.00	0.66	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	61.14	18.96	2.55	3.40	1.70	9.34	41.89	0.28	0.85	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	78.09	16.68	3.03	3.03	2.27	8.72	32.98	0.00	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	74.30	20.05	1.31	3.94	2.96	5.59	34.52	0.66	1.31	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	31.08	10.84	2.46	2.60	1.73	1.73	2.17	0.29	1.01	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	26.55	6.94	0.91	1.21	0.60	1.81	4.53	0.00	0.60	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	21.56	8.05	0.95	1.42	1.42	2.13	2.84	0.47	0.71	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	28.79	9.04	0.67	1.34	1.67	0.33	1.84	0.67	0.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	25.95	3.04	0.83	1.10	1.10	0.55	4.42	0.28	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	19.83	4.46	1.24	1.24	0.99	0.25	2.48	0.25	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	32.31	7.24	0.98	0.98	0.98	0.98	2.15	0.59	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	31.69	5.70	1.78	1.42	1.07	0.36	4.27	0.18	0.53	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	14.15	3.05	1.31	0.87	0.44	0.00	3.48	0.00	0.44	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	24.58	8.19	0.70	0.70	0.47	0.70	2.34	0.23	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	25.87	7.39	0.00	2.11	1.06	1.06	6.86	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	15.53	3.33	0.00	0.00	1.11	0.00	4.44	0.00	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	26.92	7.44	1.34	1.64	1.93	1.93	2.68	0.00	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	24.15	7.58	1.40	0.40	1.00	1.60	5.19	0.20	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.25	3.75	0.21	0.42	0.21	0.42	1.67	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	29.06	10.30	0.46	1.60	1.14	1.14	2.06	0.00	0.69	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	21.49	6.11	0.45	1.13	0.90	0.90	4.07	0.23	0.90	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	22.70	4.36	0.87	0.87	0.44	0.87	0.44	0.44	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	45.19	11.30	1.61	1.08	1.08	1.34	1.34	1.08	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	49.20	11.17	2.27	2.97	2.44	2.44	4.36	0.70	0.52	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	31.14	13.47	1.68	2.10	0.84	1.68	3.37	0.84	1.68	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	20.02	6.06	0.18	0.37	0.73	0.18	1.10	0.18	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	15.50	3.87	0.70	1.76	1.06	0.35	2.82	0.70	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	13.16	4.39	0.88	0.44	0.00	1.32	0.88	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	31.74	6.80	1.22	2.09	1.22	0.52	2.09	0.70	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	37.54	8.18	2.60	1.12	3.35	0.37	3.35	1.49	0.74	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	23.49	4.10	0.43	1.51	0.22	0.65	5.82	0.22	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	15.97	9.01	1.64	1.23	0.82	0.82	0.82	0.82	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	15.07	5.79	0.93	0.46	0.46	0.93	4.17	0.46	0.70	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.82	1.39	0.23	1.16	0.00	0.00	2.32	0.00	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	73.45	7.19	3.05	1.09	2.18	1.31	48.82	0.22	3.71	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	62.83	9.24	1.62	2.08	2.08	0.92	23.56	0.46	2.54	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	45.92	5.42	3.47	1.52	1.52	0.43	32.28	0.00	1.95	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	53.88	11.83	3.74	1.09	1.25	2.18	14.17	0.78	1.25	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	27.07	7.86	1.40	0.70	0.87	0.70	5.41	0.70	0.52	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	39.02	8.47	3.34	0.45	1.34	2.45	17.61	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	108.45	8.42	4.59	2.81	2.55	1.28	90.59	0.26	2.81	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	91.12	9.44	4.61	3.07	1.32	2.85	45.23	0.66	4.17	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	79.17	7.16	2.74	1.89	0.63	0.84	101.06	0.42	3.16	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	30.48	12.19	2.03	2.03	8.13	0.00	18.29	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	25.09	5.42	8.81	0.00	3.39	1.36	25.76	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	36.25	4.14	3.11	0.00	3.11	1.04	24.85	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	19.19	3.20	3.73	1.07	3.20	0.53	0.53	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	25.73	0.54	5.90	0.00	4.29	1.07	0.54	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	33.69	6.32	3.51	0.00	4.21	2.11	20.36	0.00	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	33.73	7.06	3.14	0.78	1.57	0.78	33.73	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	35.59	6.59	2.64	1.32	5.27	0.00	23.73	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	89.59	14.79	13.15	0.82	14.79	3.29	46.03	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	55.86	8.71	7.98	2.90	4.35	2.90	11.61	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	86.83	12.62	6.56	2.02	12.12	3.03	32.31	0.50	0.50	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	22.63	3.23	0.81	0.40	0.40	0.00	0.00	0.40	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	13.58	3.60	0.80	0.00	0.40	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	7.03	11.04	0.00	0.00	1.00	1.00	0.00	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	15.17	1.69	1.12	0.56	2.25	0.00	1.69	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	3.01	2.63	0.75	0.75	0.38	0.38	1.50	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	2.93	1.58	0.45	0.00	0.23	0.23	0.68	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	24.28	6.07	3.93	1.07	5.36	0.36	0.00	1.43	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	41.03	6.74	3.06	1.22	3.67	0.61	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	26.23	7.32	3.35	0.91	4.27	1.22	0.00	0.30	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	12.76	7.15	3.32	0.00	2.04	0.26	0.00	0.51	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	13.03	3.37	2.25	0.22	1.57	0.90	0.00	0.45	0.00	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	18.68	7.19	2.87	0.00	2.30	1.15	0.00	0.00	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	34.61	6.16	4.27	1.90	6.16	0.00	0.00	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	33.71	9.13	4.21	0.70	4.21	2.11	0.00	2.81	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	0.00	0.00	3.30	9.89	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	13.73	8.38	3.03	0.29	2.31	1.59	0.00	0.58	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	13.56	5.25	2.03	0.17	2.20	0.68	0.00	0.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	16.60	4.19	1.45	0.16	1.61	1.29	0.00	0.16	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	22.86	5.83	0.90	0.90	5.83	0.90	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	14.32	4.89	3.84	0.70	5.24	0.70	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	22.00	2.20	3.96	0.00	5.28	0.00	0.00	0.88	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	21.93	10.96	3.37	0.84	3.37	4.22	0.00	0.42	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	12.05	5.19	1.87	0.62	2.49	1.45	0.00	0.62	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	11.69	4.68	2.00	0.33	1.67	1.34	0.00	0.33	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	40.79	6.80	4.35	1.09	5.44	0.54	0.00	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	33.76	6.43	6.43	1.07	3.75	0.00	0.00	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	37.66	3.59	5.38	1.79	8.97	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	10.01	8.90	1.30	0.37	3.15	1.11	0.00	0.00	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	11.05	5.20	1.52	0.00	1.08	1.08	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	9.25	5.25	1.89	0.00	2.73	1.26	0.00	0.21	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	30.34	4.04	1.52	1.01	2.53	0.51	0.00	1.52	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	25.56	5.20	3.47	0.00	2.17	0.43	0.00	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	23.53	3.49	3.49	0.00	2.18	0.44	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	11.88	2.97	3.46	0.00	0.99	0.00	0.49	1.48	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	6.46	3.69	0.92	0.00	0.00	0.00	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	8.37	2.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	14.40	4.15	1.94	0.28	0.83	1.11	0.00	1.38	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	14.72	3.93	1.72	0.25	1.47	0.25	0.00	0.25	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	13.86	3.08	6.16	0.00	3.08	3.08	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	17.19	3.94	2.15	0.00	1.79	0.00	1.43	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	9.69	1.38	2.77	0.00	1.38	1.38	0.00	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	29.79	5.89	3.60	2.29	5.24	0.65	0.00	0.65	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	30.41	4.88	2.25	1.50	4.51	1.50	0.00	0.38	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	32.32	4.04	2.52	1.51	5.55	2.27	0.00	0.50	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	0.69	1.38	0.23	0.00	0.23	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	2.40	1.44	0.72	0.00	0.24	0.00	0.00	0.00	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	2.19	0.55	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.30	1.20	0.30	0.00	0.30	0.00	0.00	0.00	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.40	1.92	0.48	0.00	0.96	0.24	0.00	0.48	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2.27	0.91	0.23	0.45	0.00	0.00	0.00	0.00	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1.52	0.22	0.43	0.00	0.22	0.43	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	1.84	1.32	0.00	0.26	0.53	0.26	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	2.81	0.70	0.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	1.81	0.91	0.60	0.00	0.60	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	3.20	0.58	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.40	0.80	0.53	0.00	0.27	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	2.19	1.31	0.00	0.00	0.88	0.88	0.00	0.00	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	4.55	0.91	0.46	0.00	0.46	0.00	0.00	0.46	1.37	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	0.75	0.75	0.75	0.00	0.00	0.75	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.16	1.08	0.36	0.36	0.00	0.00	0.00	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2.01	1.73	0.29	0.00	0.29	0.00	0.00	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	3.06	0.71	0.24	0.24	0.47	0.24	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	1.90	0.63	0.00	0.00	0.32	0.32	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	2.46	1.54	0.00	0.00	0.62	0.62	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	1.28	0.00	0.32	0.00	0.96	0.00	0.00	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	2.29	1.91	0.00	0.00	0.76	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	2.36	0.79	0.39	0.00	0.39	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	3.78	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	13.65	4.01	0.00	1.61	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	9.09	7.69	0.00	1.40	0.70	0.70	0.00	0.00	2.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	23.04	3.01	3.01	2.00	2.00	0.00	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	69.45	16.45	3.66	1.83	1.83	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	46.44	19.76	6.42	9.39	4.45	0.00	0.00	0.00	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	12.31	9.68	1.58	3.47	0.95	0.00	0.00	0.21	0.42	0.11
Chondrocyte - de diff, donor1	11261-116G1	10.75	6.59	0.69	1.04	1.04	1.39	0.00	0.35	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	24.17	12.08	1.42	3.20	1.42	2.84	0.00	0.00	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	15.47	10.70	2.05	2.84	1.37	1.25	0.00	0.23	0.46	0.46
Chondrocyte - re diff, donor2	11339-117F7	9.85	10.74	0.90	1.79	1.79	2.69	0.00	1.79	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	19.41	14.56	1.62	4.45	3.24	2.02	0.00	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	6.08	9.41	0.69	1.72	1.15	0.00	0.00	0.23	0.11	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	4.70	6.63	0.21	1.07	0.43	0.43	0.00	0.21	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	4.78	9.38	0.97	2.12	1.24	0.53	0.00	0.09	0.00	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	38.33	13.39	4.22	2.29	2.57	4.49	3.12	1.56	0.55	0.46
Corneal Epithelial Cells, donor1	11526-119I5	8.78	10.32	1.32	0.66	0.44	0.00	0.00	0.22	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	10.24	3.41	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.14	4.09	0.26	0.26	0.51	0.26	0.00	0.51	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	53.49	11.89	2.48	1.65	1.49	1.49	23.94	0.83	0.99	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	52.99	9.78	3.47	0.32	1.26	1.58	22.39	0.63	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	6.90	0.00	0.00	0.00	0.00	17.25	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	56.80	7.34	2.38	0.86	0.86	1.19	24.19	0.65	0.97	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	16.06	4.78	0.68	0.34	1.02	0.68	5.12	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	11.75	0.65	0.00	0.00	0.00	0.65	12.40	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	17.91	5.81	0.48	0.97	0.00	0.97	13.55	0.97	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	2.50	4.17	0.33	0.83	0.17	0.17	0.00	0.17	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	5.87	5.87	0.59	0.59	0.00	0.59	0.00	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	8.77	13.29	0.57	1.98	1.41	0.28	0.00	0.28	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	4.33	3.15	0.00	0.39	1.18	0.00	0.00	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.82	7.27	0.00	1.16	0.58	0.58	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	4.24	10.12	0.24	2.12	1.18	0.47	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	5.61	7.54	1.05	1.05	0.88	0.70	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	5.32	4.65	1.33	1.11	0.44	0.22	0.00	0.00	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	6.09	5.78	0.30	0.61	0.61	0.00	0.00	0.91	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	3.95	5.92	0.56	0.56	1.13	0.00	0.00	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	4.46	8.62	0.00	0.89	0.59	0.89	0.00	0.00	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	6.25	8.85	0.52	1.56	2.08	2.08	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	4.96	7.37	0.14	1.28	1.70	1.13	0.00	0.28	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	3.20	9.60	0.00	0.80	1.20	0.80	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	3.67	7.86	0.00	0.52	1.05	1.57	0.00	0.52	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	4.10	21.37	0.50	1.99	0.62	1.12	0.00	0.75	0.00	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	6.95	10.43	0.22	1.74	1.09	0.22	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	4.89	8.79	0.85	2.32	0.49	0.85	0.00	0.37	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	2.28	5.69	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	2.10	12.57	0.00	1.40	0.70	0.70	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	1.73	5.18	0.47	1.41	1.10	0.16	0.00	0.16	0.00	0.16
Eosinophils, donor1	12244-129H3	45.74	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	3.30	0.00	1.65	0.00	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	3.57	0.00	3.57	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.18	3.91	0.00	0.24	0.73	0.49	0.00	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	25.04	13.96	1.23	2.05	1.64	0.41	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	14.12	3.83	0.88	0.44	0.55	1.09	0.00	0.00	0.33	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	9.75	5.96	0.76	1.08	0.87	0.65	0.00	0.00	0.11	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	15.16	13.22	1.21	2.55	0.73	2.06	0.00	0.12	0.24	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	22.11	6.28	3.28	0.96	1.91	0.82	0.00	0.82	0.96	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	26.05	12.23	1.27	2.32	2.00	2.11	0.00	0.11	1.05	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	32.94	18.44	1.58	3.69	2.90	1.05	0.00	1.32	1.32	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.26	8.30	1.99	4.65	1.66	1.33	0.00	0.00	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	17.69	11.34	0.45	1.81	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	16.67	17.43	0.00	2.27	3.03	0.00	0.00	0.76	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	12.78	9.94	0.95	2.21	1.10	1.26	0.00	0.63	0.00	0.32
Fibroblast - Cardiac, donor4	11452-119A3	13.94	16.67	1.82	5.76	2.42	2.12	0.00	0.00	0.61	0.61
Fibroblast - Cardiac, donor5	11456-119A7	7.61	9.52	0.38	2.54	1.02	0.38	0.00	0.00	0.25	0.25
Fibroblast - Cardiac, donor6	11460-119B2	9.55	7.43	0.45	1.36	0.30	0.15	0.00	0.00	0.15	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.99	34.57	3.35	8.71	2.81	0.67	0.00	0.40	2.14	1.88
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.94	18.98	1.73	5.61	1.73	1.73	0.00	0.00	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	5.86	10.25	1.46	1.46	1.46	0.00	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	8.53	17.53	1.15	2.08	0.92	0.00	0.00	0.69	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	10.35	21.20	0.85	5.26	1.87	0.34	0.00	0.00	0.51	0.68
Fibroblast - Dermal, donor1	11269-116G9	6.57	5.40	0.00	0.23	0.47	0.70	0.00	0.47	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	6.13	2.83	1.42	0.00	0.47	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	4.59	3.99	0.60	0.48	0.24	0.97	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	3.62	3.62	0.34	0.45	0.57	0.34	0.00	0.00	0.11	0.23
Fibroblast - Dermal, donor5	11454-119A5	3.31	3.84	0.35	0.00	0.35	0.00	0.00	0.17	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	3.09	3.74	0.00	0.32	0.00	0.00	0.00	0.16	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	8.12	10.00	0.62	0.42	0.62	1.04	0.00	0.21	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	14.15	12.05	1.05	2.62	2.10	2.36	0.00	0.00	0.00	1.31
Fibroblast - Gingival, donor2	11318-117D4	3.43	4.61	1.05	0.66	0.53	0.26	0.00	0.26	0.13	0.26
Fibroblast - Gingival, donor3	11394-118C8	11.89	18.66	1.26	3.00	1.55	0.19	0.00	0.00	0.39	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	31.17	22.86	3.12	7.27	1.04	3.12	0.00	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	33.48	14.10	2.29	2.47	0.70	2.47	0.00	1.23	0.35	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	11.69	8.73	0.94	1.87	1.25	0.31	0.00	0.16	0.00	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	12.58	12.17	0.41	0.68	0.68	0.41	0.00	0.27	0.00	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	77.28	47.64	3.88	6.00	4.59	2.82	0.00	1.76	1.06	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	18.72	12.72	1.17	1.46	1.90	0.73	0.00	0.73	0.44	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	12.54	10.91	0.41	1.64	0.82	1.23	0.00	0.27	0.14	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	8.01	9.32	0.22	0.88	1.32	0.33	0.00	0.11	0.00	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	37.86	22.30	2.20	4.40	2.35	4.55	0.00	0.88	0.44	0.59
Fibroblast - Lung, donor1	11270-116H1	0.00	8.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	2.98	4.48	0.00	5.97	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	3.80	8.23	0.42	0.42	0.63	0.21	0.00	0.00	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	48.32	26.66	2.50	4.17	1.67	1.67	0.00	0.83	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	27.97	11.19	2.80	1.40	1.40	1.40	0.00	2.80	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	24.91	17.63	0.84	1.40	0.28	0.84	0.00	0.84	1.12	0.84
Fibroblast - Mammary, donor1	11540-120B1	22.33	15.43	2.03	0.81	0.41	0.81	0.00	1.22	1.62	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	23.83	0.00	0.00	0.00	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	1.36	3.10	0.00	0.78	0.19	0.00	0.00	0.19	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	3.94	6.07	0.76	0.61	0.76	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	8.26	4.90	0.61	0.00	0.31	0.61	0.00	0.00	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.73	8.78	1.53	2.67	1.91	0.00	0.00	0.00	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	26.46	15.93	2.43	2.43	1.35	0.81	0.00	1.35	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	34.44	12.99	1.39	3.94	1.16	3.25	0.00	0.23	0.70	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	5.31	4.31	0.88	1.33	1.11	0.11	0.00	0.44	0.11	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	14.63	31.70	0.81	3.25	2.03	0.61	0.00	0.81	0.20	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	5.35	5.35	0.67	2.67	0.00	0.67	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	3.16	5.93	1.19	1.58	0.40	0.00	0.00	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	16.07	11.91	1.39	1.39	1.19	0.40	0.00	0.00	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.41	12.26	1.07	2.66	0.71	0.36	0.00	0.18	0.53	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.40	6.11	0.59	1.77	0.39	0.39	0.00	0.20	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.65	18.05	0.90	1.81	3.31	0.30	0.00	0.90	1.20	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.76	12.20	0.76	1.84	0.76	0.43	0.00	0.54	0.43	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	18.98	11.64	2.78	2.02	1.01	0.51	0.00	0.25	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	25.76	14.11	1.64	2.95	1.15	0.82	0.00	0.66	0.49	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	20.65	15.44	2.61	1.80	2.81	1.20	0.00	1.80	1.80	0.20
Fibroblast - skin normal, donor2	11561-120D4	17.78	10.65	0.90	3.01	1.71	0.80	0.00	0.40	0.40	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	12.39	9.97	2.72	1.51	2.42	1.81	0.00	1.21	0.30	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.91	10.27	1.16	1.74	1.08	0.41	0.00	0.25	0.33	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	14.02	12.65	0.68	3.08	1.20	0.68	0.00	0.00	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	34.16	19.71	2.63	1.31	2.30	1.31	0.00	0.99	1.31	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.11	12.68	0.96	2.02	1.07	1.60	0.00	0.21	0.75	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	8.10	9.45	2.02	1.01	1.01	0.17	0.00	0.17	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.94	6.43	0.63	0.78	0.94	0.47	0.00	0.31	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.89	6.97	0.00	0.87	0.87	0.87	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	5.03	2.95	0.17	0.00	0.00	0.52	0.00	0.00	0.17	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	7.55	5.99	0.78	0.52	1.04	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	4.34	2.81	0.51	0.26	0.26	0.00	0.00	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	2.30	9.19	0.00	5.36	0.00	4.59	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1.91	7.66	1.28	1.28	0.00	0.64	0.00	0.00	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	4.28	5.42	0.86	2.00	0.57	0.57	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	5.24	23.44	0.55	12.68	0.83	4.41	0.00	0.83	0.83	1.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	8.45	13.24	0.46	7.76	1.37	2.05	0.00	0.23	0.91	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	4.36	8.12	1.39	4.76	0.99	1.39	0.00	0.79	0.00	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	5.02	19.83	0.79	8.72	1.06	3.17	0.00	0.26	0.53	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	9.46	10.11	1.30	7.18	0.98	0.98	0.00	0.33	0.00	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3.10	4.86	0.44	3.54	0.44	1.77	0.00	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	5.94	5.51	1.55	1.98	1.27	0.42	0.00	0.00	0.57	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	7.39	8.00	1.60	3.32	1.11	0.49	0.00	0.00	0.62	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	1.07	6.18	1.61	1.07	0.54	0.27	0.00	0.00	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	6.07	7.31	1.73	1.98	1.12	0.37	0.00	0.12	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	3.32	6.09	2.21	1.66	0.83	0.00	0.00	0.42	0.14	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	2.64	5.49	0.41	1.83	0.81	0.61	0.00	0.41	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	2.97	11.41	0.68	2.97	1.60	0.23	0.00	0.23	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	3.36	7.85	1.37	1.99	1.87	0.37	0.00	0.00	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	3.50	6.99	1.09	3.06	1.31	0.00	0.00	0.22	1.09	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	3.84	10.93	2.36	5.32	0.89	0.89	0.00	0.00	0.59	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	4.45	10.49	1.27	3.81	0.64	0.64	0.00	0.16	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	2.23	10.50	1.56	2.46	0.45	0.67	0.00	0.00	1.34	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	3.63	13.11	1.61	4.03	1.21	0.20	0.00	0.40	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	3.39	6.96	0.68	3.05	0.68	0.34	0.00	0.51	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	3.46	14.36	2.31	3.72	1.60	0.80	0.00	0.18	0.71	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	4.27	25.91	1.87	8.74	2.08	1.14	0.00	0.31	0.83	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	3.07	16.57	1.54	4.44	2.22	0.17	0.00	0.17	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	3.87	13.28	1.44	3.43	1.00	0.55	0.00	0.22	0.33	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	4.83	14.73	1.66	4.24	1.25	0.67	0.00	0.17	0.92	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	3.68	12.25	1.63	3.06	1.43	0.82	0.00	0.20	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	3.30	13.00	0.83	4.54	1.44	0.41	0.00	0.00	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	4.96	14.41	1.27	3.80	0.92	0.92	0.00	0.12	0.46	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	3.67	9.84	0.50	3.67	0.50	1.50	0.00	0.00	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	4.19	10.80	1.32	4.41	1.98	1.32	0.00	0.66	0.22	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	4.55	14.39	1.60	4.18	1.23	0.25	0.00	0.00	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	4.70	10.37	1.13	3.89	1.30	0.97	0.00	0.16	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	5.13	19.88	1.28	6.74	3.53	4.49	0.00	1.28	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	4.07	8.91	1.04	2.75	1.33	0.47	0.00	0.19	0.19	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	2.53	11.55	1.27	3.16	0.79	0.95	0.00	0.32	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	3.04	10.64	0.91	2.43	2.13	2.13	0.00	0.30	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	3.24	8.26	0.84	2.51	0.84	0.52	0.00	0.00	0.31	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	3.95	12.73	1.10	4.39	1.98	1.32	0.00	0.00	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	4.21	11.50	0.84	1.68	1.12	0.56	0.00	0.00	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	5.18	11.02	0.65	1.48	1.02	0.56	0.00	0.00	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	2.67	8.82	0.80	1.07	1.34	1.07	0.00	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	2.60	6.12	0.61	0.61	0.61	0.31	0.00	0.15	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	2.72	6.74	0.13	0.91	1.04	0.00	0.00	0.00	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	5.15	10.57	0.54	2.17	1.63	0.27	0.00	0.54	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	2.77	13.64	0.18	1.66	1.29	0.37	0.00	0.37	0.00	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	5.26	12.94	1.32	4.39	1.75	0.88	0.00	0.44	0.22	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	15.87	37.69	0.99	4.96	3.97	2.98	0.00	0.99	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	5.01	10.03	1.06	1.32	1.98	0.66	0.00	0.53	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	5.45	13.11	1.61	1.82	1.41	0.61	0.00	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	26.18	53.63	3.05	15.76	3.81	2.29	0.00	1.02	0.51	2.03
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	4.38	4.58	1.00	2.19	1.00	0.00	0.00	0.00	0.20	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	3.85	3.85	0.77	1.69	0.77	0.31	0.00	0.15	0.31	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	4.30	5.11	0.61	1.64	0.82	0.00	0.00	0.20	0.61	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1.88	5.01	0.00	1.88	0.00	0.31	0.00	0.00	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	0.85	1.70	0.28	1.41	0.00	0.28	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2.77	5.07	0.00	1.38	0.46	0.00	0.00	0.00	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	2.47	0.00	0.00	2.47	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	3.09	3.48	0.77	1.93	0.77	0.00	0.00	0.00	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4.81	6.42	0.00	0.00	1.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1.74	5.22	1.74	5.22	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1.30	6.18	0.65	2.28	1.30	0.33	0.00	0.00	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	2.06	5.77	0.00	2.06	0.82	0.41	0.00	0.00	1.65	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	10.00	0.00	3.33	10.00	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	2.80	5.59	0.56	1.96	0.00	0.28	0.00	0.00	1.12	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	2.29	7.19	0.00	2.29	0.00	0.33	0.00	0.00	1.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	6.71	9.23	1.68	5.87	0.00	1.68	0.00	0.00	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	3.18	10.18	0.32	4.77	0.64	0.00	0.00	0.00	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	3.06	7.13	1.02	2.72	1.02	0.68	0.00	0.34	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	6.26	0.00	0.00	0.00	4.18	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	3.44	15.46	0.00	5.15	0.57	1.15	0.00	0.00	1.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	2.37	5.62	0.89	2.96	1.18	0.30	0.00	0.00	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	5.08	11.86	0.00	6.78	1.69	0.00	0.00	0.00	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	4.56	8.70	1.24	2.07	0.41	0.00	0.00	0.00	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	2.76	7.59	0.23	2.53	0.23	1.15	0.00	0.23	1.15	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	21.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	3.08	4.23	0.38	4.61	0.00	0.38	0.00	0.00	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	1.63	5.54	0.00	2.28	0.98	0.33	0.00	0.00	1.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	3.34	6.69	0.00	6.69	0.67	0.00	0.00	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	1.54	13.10	0.77	5.01	0.39	2.31	0.00	0.00	1.16	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	5.82	7.53	0.68	6.16	1.03	1.03	0.00	0.34	3.08	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	2.48	12.42	2.48	4.97	2.48	0.00	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	5.66	9.91	0.47	10.38	1.89	1.42	0.00	0.00	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	4.22	12.07	0.00	6.03	0.60	1.21	0.00	0.00	1.81	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	2.54	13.73	0.00	9.16	0.00	1.53	0.00	0.00	2.03	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	3.19	13.16	0.40	6.78	0.80	1.99	0.00	0.00	0.80	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	3.45	14.31	0.49	4.93	0.99	0.99	0.00	0.00	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	8.26	10.62	1.18	2.36	1.18	1.18	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	3.50	6.42	0.58	7.58	0.00	1.17	0.00	0.00	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	4.39	14.04	0.44	10.53	0.44	0.88	0.00	0.00	3.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	7.63	8.48	0.00	4.24	1.70	0.00	0.00	0.00	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	2.39	8.36	0.60	4.18	0.60	0.00	0.00	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	3.88	5.82	0.49	2.91	0.00	1.46	0.00	0.00	1.94	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	20.54	0.00	6.85	3.42	2.28	0.00	1.14	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	32.02	18.30	3.33	4.99	4.57	1.66	0.00	0.42	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	22.49	10.12	0.00	3.37	1.12	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	28.23	6.03	0.95	1.59	0.95	0.63	0.00	0.32	0.63	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	26.74	5.01	2.09	2.09	0.84	1.25	0.00	0.42	0.84	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	9.05	5.69	1.62	0.81	1.74	0.12	0.00	0.46	0.23	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	7.43	4.39	1.35	0.17	1.52	0.51	0.00	0.34	0.51	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	7.74	5.23	1.14	0.68	1.14	0.23	0.00	0.00	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	9.62	5.14	1.09	0.44	1.42	0.44	0.00	0.00	0.00	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	9.46	3.65	1.07	0.21	1.50	0.00	0.00	0.00	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	8.40	2.58	1.08	0.86	0.65	0.00	0.00	0.00	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	10.59	4.11	1.00	1.49	1.00	0.62	0.00	0.12	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	8.06	5.66	1.37	1.20	1.03	0.17	0.00	0.17	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.09	3.20	1.28	0.64	0.96	0.96	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	7.83	20.15	0.00	2.24	1.12	1.68	0.00	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.22	12.98	0.87	1.30	1.73	0.87	0.00	1.30	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	2.64	0.00	0.00	0.00	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	20.81	17.64	1.06	2.82	1.76	0.00	0.00	0.35	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	16.71	17.44	0.73	4.36	0.73	0.00	0.00	0.00	1.45	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	5.42	4.90	1.05	1.57	0.35	0.00	0.00	0.17	0.00	0.00
Hepatocyte, donor1	11523-119I2	47.21	4.84	1.21	0.00	1.21	3.63	0.00	2.42	2.42	0.00
Hepatocyte, donor2	11603-120I1	18.31	7.54	0.00	0.00	0.00	2.15	0.00	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	44.79	8.59	1.23	1.23	2.45	1.84	0.61	1.23	1.84	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	5.87	4.57	1.96	0.00	0.65	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	21.32	15.21	1.92	2.97	1.75	1.05	0.00	0.87	6.12	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	4.67	4.25	0.55	0.82	0.82	0.00	0.00	0.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	9.55	3.18	3.18	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	0.00	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	9.69	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	15.02	5.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	12.81	5.13	0.00	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	9.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	9.75	1.62	0.00	1.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	6.67	0.00	0.00	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	27.79	7.94	5.29	1.32	7.94	1.32	0.00	0.00	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	8.87	9.98	1.11	1.11	2.22	0.00	0.00	1.11	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	15.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	21.42	9.45	0.63	0.63	1.26	0.63	0.00	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	7.73	1.55	1.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.26	14.86	3.88	1.94	2.58	0.00	0.00	0.65	1.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	22.54	11.27	1.61	1.61	3.22	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	14.67	13.85	0.81	0.81	3.26	0.81	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.21	15.95	2.10	0.84	1.68	2.10	0.00	0.84	0.84	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	24.91	10.45	1.61	0.00	2.41	0.00	0.00	0.80	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	8.31	6.46	3.69	0.00	2.77	0.92	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	10.86	5.19	0.94	0.47	0.94	0.47	0.00	0.47	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	13.60	0.91	0.91	0.91	0.91	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	31.21	15.07	2.15	2.15	1.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	20.33	8.89	1.27	2.54	6.35	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	21.04	10.20	3.19	0.64	2.55	0.00	0.00	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	3.65	5.47	0.00	3.65	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	27.13	14.28	0.71	0.71	1.43	0.71	0.00	1.43	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	3.32	0.00	0.00	0.00	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	14.51	8.64	1.54	1.23	2.78	0.00	0.00	0.31	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	3.51	0.00	0.00	3.51	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	6.29	0.00	3.14	9.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.73	11.13	2.09	1.39	3.48	0.00	0.00	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	22.13	11.07	2.21	2.21	4.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	38.90	9.73	3.24	0.00	0.00	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.93	14.82	0.87	0.00	0.87	0.87	0.00	2.62	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	15.75	2.25	0.00	0.00	2.25	0.00	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	13.94	0.00	0.00	3.48	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	24.54	21.34	3.20	3.20	6.40	0.00	0.00	0.00	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	16.63	11.08	1.39	0.00	2.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	5.70	0.00	2.85	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	20.25	11.05	2.76	0.00	0.92	0.00	0.00	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	21.18	0.00	3.03	9.08	0.00	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	18.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	22.20	9.52	3.17	4.23	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	9.47	8.00	0.90	0.65	0.65	1.14	0.00	0.49	0.08	0.24
Keratinocyte - epidermal, donor2	11349-117G8	4.69	7.03	0.00	0.00	0.59	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	4.16	3.03	0.28	0.19	0.38	0.00	0.00	0.09	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	7.15	9.54	0.79	0.91	1.02	0.34	0.00	0.23	0.00	0.34
Keratocytes, donor1	11527-119I6	5.85	17.88	0.69	1.38	1.03	0.34	0.00	0.00	0.00	0.34
Keratocytes, donor2	11607-120I5	14.06	7.03	0.00	0.00	0.00	1.17	0.00	0.00	1.17	1.17
Keratocytes, donor3	11688-122I5	2.57	7.31	0.40	1.58	0.79	0.20	0.00	0.00	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	15.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	4.31	6.47	1.08	1.08	1.08	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	2.19	10.84	1.38	1.96	0.81	0.00	0.00	0.12	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	14.63	12.11	2.42	2.83	2.22	0.10	0.00	0.61	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	3.56	9.96	0.71	1.66	0.83	0.59	0.00	0.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	2.79	5.30	0.56	0.28	0.28	0.00	0.00	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	4.41	7.24	0.63	0.94	1.10	0.47	0.00	0.31	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	4.30	6.99	0.00	1.08	0.00	0.54	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	2.52	8.82	1.26	1.26	0.95	0.32	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	2.91	6.15	0.43	0.97	0.75	0.22	0.00	0.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	2.05	6.57	0.00	0.00	2.05	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.26	5.81	0.00	0.76	0.00	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	3.52	8.30	0.28	0.99	1.55	0.14	0.00	0.14	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	1.19	8.31	0.00	1.98	0.79	0.00	0.00	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	2.52	7.95	0.39	0.78	0.58	0.58	0.00	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.04	8.52	1.11	0.56	1.11	0.37	0.00	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	2.79	7.67	0.35	0.70	0.00	0.00	0.00	0.35	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	1.19	7.63	0.72	0.48	0.95	0.48	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	1.65	7.69	0.69	0.96	0.41	0.27	0.00	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	2.46	6.78	0.31	1.23	0.62	0.31	0.00	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1.56	7.17	0.00	0.94	0.94	0.00	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	4.03	8.23	0.55	1.10	0.91	0.18	0.00	0.18	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	1.97	5.27	0.00	1.32	0.66	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.34	5.27	0.88	2.05	1.17	0.29	0.00	0.00	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.73	8.46	0.50	1.49	0.75	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	1.45	6.30	0.97	0.00	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	1.62	5.92	0.00	0.54	0.00	0.27	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	5.60	8.17	0.30	0.30	1.67	0.15	0.00	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	1.04	5.70	0.52	0.00	0.52	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	1.47	7.33	0.42	0.21	1.26	0.21	0.00	0.00	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.31	7.52	0.15	0.90	1.20	0.00	0.00	0.15	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	2.06	4.82	0.69	1.38	0.69	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	1.32	6.77	0.19	1.32	0.38	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	2.65	8.59	0.11	0.95	0.53	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	2.91	6.78	0.00	0.48	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	1.98	8.60	0.33	0.99	0.33	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	3.10	7.56	0.25	1.49	1.98	0.12	0.00	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	4.81	8.51	0.37	1.11	0.74	0.37	0.00	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	1.24	5.19	0.00	0.74	0.25	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.89	7.15	0.14	0.96	1.10	0.14	0.00	0.00	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	0.64	9.33	0.32	2.25	0.64	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	2.13	9.13	0.30	2.13	0.30	0.30	0.00	0.00	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	3.64	5.60	0.00	0.56	0.42	0.14	0.00	0.28	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	2.49	4.62	0.00	1.07	0.71	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.42	8.73	0.48	0.48	1.45	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.89	7.94	0.47	1.40	1.24	0.62	0.00	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	1.43	4.66	0.36	0.36	0.72	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	1.31	5.88	0.33	0.33	0.65	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.30	7.30	0.47	1.18	1.18	0.47	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	2.72	9.03	1.11	1.24	1.61	0.37	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	0.51	9.22	0.26	1.02	0.26	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	3.28	5.37	0.00	0.30	0.90	0.00	0.00	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	0.00	0.00	0.00	4.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	8.44	0.77	0.00	0.00	0.00	1.53	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.88	0.00	0.74	0.00	0.74	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	6.77	2.12	0.85	0.42	0.42	0.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.14	1.41	0.70	0.00	0.00	0.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	2.80	0.93	0.00	0.93	0.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	1.55	0.52	0.00	0.52	0.52	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	1.19	4.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	6.33	0.90	1.58	0.00	0.23	0.00	0.00	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.82	2.04	0.00	0.29	0.00	0.29	0.00	0.87	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	8.10	0.90	0.90	0.00	0.00	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	10.84	3.25	1.90	0.00	0.68	0.00	0.00	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.22	2.05	0.00	0.51	1.54	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	4.23	0.71	0.71	1.06	0.71	0.00	0.00	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	4.00	0.00	2.00	0.67	0.67	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	5.09	1.02	1.02	0.00	0.00	1.02	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	7.47	1.07	1.33	0.00	0.53	0.27	0.00	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	6.24	1.32	0.94	0.19	0.38	0.38	0.00	0.57	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.75	1.84	1.23	0.00	0.61	0.00	0.00	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	4.08	2.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	5.41	1.04	2.08	0.42	0.42	0.42	0.00	0.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	7.01	1.68	0.56	0.28	0.84	0.28	0.00	0.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	5.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	4.64	1.74	0.87	0.87	0.87	0.00	0.00	0.58	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	3.59	1.20	0.00	0.30	0.00	0.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	7.19	1.66	1.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	7.07	3.18	1.06	0.35	1.06	1.06	0.00	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	5.53	0.74	1.11	0.37	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	11.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	9.59	3.07	0.77	0.77	0.38	0.00	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	3.96	3.40	0.57	0.00	0.57	2.26	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.03	3.28	0.00	0.00	0.00	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.49	0.45	0.90	0.90	0.45	0.00	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	2.87	0.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.96	0.75	1.49	0.75	0.00	0.00	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	11.89	2.97	1.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	3.88	0.86	0.86	0.43	0.86	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.14	2.57	2.57	0.00	0.86	0.86	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	8.33	2.33	1.67	0.33	0.00	0.00	0.00	0.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	9.05	1.81	1.21	0.00	0.60	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	10.66	2.13	0.00	0.71	0.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	7.56	1.37	2.06	0.34	0.34	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.44	4.83	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.75	0.67	0.67	0.00	1.35	2.02	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	7.41	3.33	1.11	0.00	0.37	0.74	0.00	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	2.33	2.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	10.58	0.00	0.00	0.00	1.06	0.00	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.80	2.40	0.40	0.00	0.00	0.80	0.00	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.00	1.45	0.73	0.00	0.00	0.00	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	11.50	0.77	4.60	0.77	0.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	11.35	2.47	1.48	0.49	0.49	0.49	0.00	0.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	4.70	0.94	2.82	0.00	0.00	2.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	10.06	2.01	1.01	0.00	0.50	1.01	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	9.46	3.15	0.90	0.00	1.35	0.90	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	0.00	1.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	10.24	3.12	0.89	0.89	0.00	0.45	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.56	2.35	1.96	0.00	0.39	0.00	0.00	0.78	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	1.32	1.32	1.98	0.00	0.00	0.66	0.00	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	6.75	4.67	1.56	0.00	1.04	1.04	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	6.56	0.44	0.88	0.00	0.44	0.88	0.00	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.83	3.91	0.00	0.00	0.00	0.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	7.07	0.88	0.00	0.00	0.44	0.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	12.73	1.16	1.16	0.77	0.00	0.77	0.00	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.08	0.51	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	9.13	1.92	0.48	0.00	0.00	0.00	0.00	0.00	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.13	1.99	1.19	1.19	1.19	1.19	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7.90	6.08	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	5.53	2.77	0.00	0.00	0.69	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	8.36	0.76	1.52	0.00	1.14	0.38	0.00	0.38	1.14	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	6.71	0.00	0.00	0.00	0.00	1.03	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.65	0.60	0.00	1.21	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	5.70	1.90	0.32	0.32	0.32	0.63	0.00	0.00	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.53	1.07	0.53	0.00	0.00	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	7.47	2.30	0.00	1.15	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	7.20	1.03	0.00	0.51	0.51	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.78	1.41	0.00	0.71	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	12.48	3.40	0.00	0.57	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	7.07	3.74	2.08	0.00	0.83	0.42	0.00	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	11.75	3.92	1.57	0.00	0.00	0.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.52	2.09	0.84	0.84	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	7.43	1.86	0.00	0.46	0.00	0.46	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	5.35	2.68	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	6.42	0.53	3.21	0.53	0.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	4.85	3.23	0.81	0.00	0.40	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	0.92	0.92	0.00	0.92	0.00	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	3.56	0.89	0.00	0.89	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	4.56	1.14	2.28	0.00	0.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	4.60	1.53	0.00	0.00	0.77	0.00	0.00	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	5.47	1.64	0.55	0.55	1.09	0.00	0.00	1.09	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	4.45	2.67	1.78	0.89	0.00	0.45	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	7.80	2.86	2.08	1.04	0.78	0.26	0.00	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	6.63	2.65	0.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	2.08	0.00	2.08	0.00	0.00	0.00	2.08	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	49.23	10.94	2.96	0.68	1.82	1.14	6.61	0.46	0.91	0.00
Macrophage - monocyte derived, donor2	11313-117C8	17.62	3.67	0.73	0.73	0.37	0.73	1.65	0.73	0.73	0.00
Macrophage - monocyte derived, donor3	11389-118C3	38.93	5.64	1.70	0.13	0.52	0.92	2.36	1.05	0.39	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.66	2.66	0.00	0.00	0.53	0.53	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	8.56	5.23	0.95	0.00	0.79	0.00	0.00	0.63	0.16	0.32
Mallassez-derived cells, donor3	11930-125I4	5.42	3.34	0.00	0.14	0.56	0.28	0.00	0.14	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	3.49	4.58	0.70	0.00	1.00	0.40	0.00	0.20	0.00	0.20
Mammary Epithelial Cell, donor2	11350-117G9	3.76	2.61	0.87	0.00	0.00	0.00	0.00	0.29	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	2.00	1.75	1.00	0.25	0.50	0.00	0.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	3.39	0.00	0.00	0.00	0.68	0.68	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	5.19	2.92	1.19	0.22	0.65	0.76	0.00	0.32	0.00	0.11
Mast cell, donor2	11565-120D8	17.53	7.73	0.59	0.30	0.59	2.67	0.00	0.59	0.00	0.00
Mast cell, donor3	11566-120D9	27.92	6.30	1.35	0.90	1.35	3.38	0.00	1.58	0.23	0.00
Mast cell, donor4	11567-120E1	15.60	6.56	1.24	1.24	0.89	3.19	0.00	1.06	0.18	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	13.20	4.10	2.66	0.55	1.11	1.11	0.00	0.55	0.11	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	13.42	7.00	2.33	0.00	0.58	4.67	0.00	1.17	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	4.82	2.29	0.69	0.11	0.34	1.84	0.00	0.34	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	13.56	8.03	2.68	0.50	2.85	5.36	0.00	0.50	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	2.69	9.25	0.30	1.19	1.29	0.30	0.00	0.00	0.00	0.20
Melanocyte - dark, donor2	11582-120F7	39.11	16.96	3.81	6.92	3.46	0.00	0.00	0.00	1.73	0.35
Melanocyte - dark, donor3	11663-122F7	4.06	5.36	0.87	0.43	0.22	0.07	0.00	0.07	0.00	0.29
Melanocyte - light, donor1	11274-116H5	7.99	9.87	0.94	1.18	0.24	2.59	0.00	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	12.28	14.33	0.68	1.36	0.68	3.41	0.00	0.68	0.00	0.68
Melanocyte - light, donor3	11423-118G1	7.81	9.54	3.47	1.73	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	4.69	4.37	0.52	0.52	0.10	0.10	0.00	0.10	0.00	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	10.22	3.77	0.00	1.08	1.08	0.54	0.00	0.54	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	10.71	8.30	0.54	0.80	0.54	0.00	0.00	0.80	0.00	0.00
Meningeal Cells, donor1	11493-119E8	5.46	15.14	1.12	1.36	0.62	0.00	0.00	0.62	0.12	0.12
Meningeal Cells, donor2	11573-120E7	6.16	10.56	0.88	0.44	1.32	0.00	0.00	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	3.83	10.02	0.57	0.90	0.82	0.24	0.00	0.33	0.16	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	3.99	9.70	1.43	0.86	0.57	0.57	0.00	0.57	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	7.25	7.55	0.60	1.11	1.61	0.50	0.00	0.20	0.40	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	85.42	40.74	0.00	11.83	1.31	3.94	0.00	1.31	6.57	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	24.86	7.85	0.00	1.31	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.89	3.59	0.00	0.72	0.72	0.72	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	16.31	18.85	0.64	4.02	1.91	1.91	0.00	0.00	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.07	13.07	2.01	1.51	1.01	2.01	0.00	0.50	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	16.70	12.31	1.32	1.54	0.88	0.22	0.00	0.22	0.66	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	3.65	0.73	1.46	0.00	0.73	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.46	6.96	0.41	1.02	0.82	0.00	0.00	0.61	0.41	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	39.75	14.96	2.91	4.02	0.69	0.42	0.00	0.42	1.39	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	27.14	35.69	2.97	5.20	0.74	0.37	0.00	0.37	1.86	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	16.32	21.18	2.37	4.61	0.79	0.13	0.00	0.66	0.92	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.34	22.85	0.89	8.31	0.89	1.48	0.00	0.00	8.31	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	11.68	0.00	0.00	2.34	0.00	0.00	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	6.40	11.53	1.28	0.00	0.64	0.00	0.00	0.00	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	7.09	4.25	1.42	1.42	0.00	0.00	0.00	1.06	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	12.20	13.45	0.31	4.07	0.31	0.63	0.00	0.31	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	3.63	13.06	4.35	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	20.68	5.83	1.33	0.80	1.33	2.39	0.00	0.53	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	9.01	6.01	1.00	1.50	0.50	1.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	10.55	3.32	1.59	0.29	0.65	0.87	0.00	0.22	0.07	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	8.10	0.00	0.00	1.35	0.00	0.00	1.35	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	27.09	7.14	0.49	0.74	1.23	0.74	1.48	0.49	1.23	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	22.38	5.30	0.88	0.59	0.29	1.18	1.18	0.29	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	0.00	0.00	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.43	8.06	0.62	0.00	0.31	0.62	0.62	0.62	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	17.84	6.43	1.87	0.83	0.62	0.83	0.83	1.24	0.83	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	2.32	0.00	0.00	0.00	0.00	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	26.03	5.51	1.50	0.25	0.75	1.75	1.00	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	25.14	4.19	1.40	0.47	0.93	0.47	0.47	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	25.40	6.30	1.22	0.81	0.41	0.61	1.02	0.20	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.03	6.34	1.19	0.79	1.58	0.40	1.19	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	20.35	0.88	0.88	0.00	0.88	0.00	1.77	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	22.42	4.18	0.38	1.52	0.76	0.38	1.52	1.14	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	2.63	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.04	3.61	0.64	0.21	0.21	0.42	1.70	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	2.76	0.00	0.00	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	21.16	2.98	0.30	0.60	0.30	0.00	0.30	1.19	0.30	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	3.35	0.00	1.68	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	17.06	4.27	1.76	0.25	0.50	0.00	1.51	0.00	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	18.54	4.04	0.48	0.48	0.24	1.43	0.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	7.74	2.21	0.55	0.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	13.35	1.61	0.46	0.69	0.23	0.46	1.15	0.00	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.51	3.16	0.00	1.26	0.84	0.21	0.42	0.84	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	16.10	3.67	1.02	0.61	0.82	0.20	0.20	0.61	0.82	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	19.95	1.93	0.21	0.21	0.21	0.21	0.64	0.21	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	17.34	4.00	0.44	0.22	0.00	0.00	0.67	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	15.55	2.19	1.10	0.22	0.00	0.00	0.44	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.74	3.55	0.00	0.51	0.00	0.51	0.51	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	0.00	0.00	0.00	1.66	0.00	0.00	1.66	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	22.02	3.53	0.54	0.54	0.27	1.09	0.54	0.82	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	24.41	5.00	1.18	0.00	0.29	0.29	0.59	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	15.26	5.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	15.38	6.73	0.00	0.48	0.00	0.48	1.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	26.42	4.40	1.20	1.60	0.80	0.00	0.80	0.80	0.80	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	0.00	0.00	1.37	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.02	1.50	1.00	1.00	0.50	0.00	1.50	0.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	28.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	22.33	2.63	1.75	1.75	1.31	0.00	1.31	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	16.55	1.10	1.10	0.00	0.00	0.00	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	26.26	2.56	1.28	0.00	0.00	0.00	0.00	0.00	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	22.06	2.73	0.50	0.25	1.49	0.99	1.49	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	0.70	1.39	0.70	0.70	0.00	0.70	1.39	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	25.30	4.10	0.68	0.34	1.03	0.34	0.00	0.68	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	26.69	1.31	0.44	0.00	1.75	0.00	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	28.41	2.13	0.36	0.36	0.36	0.00	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.19	4.49	0.56	1.12	0.84	0.84	0.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	18.29	6.65	0.83	0.00	0.83	0.42	0.83	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	22.73	1.17	0.58	0.00	1.75	0.58	0.00	1.17	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	14.78	6.94	1.21	0.30	0.30	0.00	0.30	0.00	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	22.12	3.34	2.09	0.83	0.83	0.00	0.42	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	21.24	2.77	0.00	0.00	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	36.99	7.97	1.14	1.71	2.28	1.14	0.57	1.14	2.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	23.08	3.59	0.83	0.41	1.11	0.28	0.14	0.28	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	20.73	6.74	1.30	0.26	1.30	0.26	0.26	1.04	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	39.47	5.15	0.00	0.86	0.86	0.86	0.86	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	20.96	3.18	1.91	0.64	2.54	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	19.22	4.80	1.07	0.27	1.33	0.00	0.53	1.33	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	18.86	3.59	0.90	0.30	1.20	0.60	0.60	0.60	0.60	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.56	2.54	0.71	0.00	0.14	0.42	0.14	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	26.12	5.41	0.64	0.64	1.59	0.32	0.96	0.64	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	31.84	4.64	1.11	1.33	0.88	0.88	0.44	0.66	1.11	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	17.82	3.41	0.76	0.00	1.14	0.38	0.00	0.38	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	23.30	6.82	0.85	0.28	0.57	0.57	0.00	1.99	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	22.12	7.37	0.49	0.49	0.98	0.25	0.98	1.72	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.78	2.61	0.00	0.00	1.30	0.65	0.65	0.65	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.94	3.82	0.00	0.29	1.47	0.29	0.00	0.29	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	9.23	5.48	0.29	0.29	0.29	0.58	0.00	1.15	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.95	6.18	0.82	0.00	0.82	0.00	0.00	0.82	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.29	6.25	0.60	0.30	2.38	0.89	0.00	0.30	1.49	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	0.00	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	33.51	7.56	2.30	0.99	0.66	0.66	1.97	0.66	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	29.45	2.10	3.16	0.00	1.05	1.05	0.00	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	18.38	2.57	0.20	0.59	0.20	0.40	0.20	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	28.87	1.86	0.00	1.86	0.93	1.86	0.93	0.00	1.86	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	32.67	4.88	2.25	0.38	0.75	1.88	2.25	0.38	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	21.31	3.46	0.80	0.53	0.27	0.80	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	11.65	2.83	1.13	0.00	0.23	0.34	0.79	0.45	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	34.63	5.16	1.47	0.00	0.74	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	30.78	4.40	0.73	0.73	0.73	1.10	1.10	0.00	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	37.33	4.67	0.00	0.00	0.00	3.11	4.67	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	11.76	0.53	0.00	0.53	0.53	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	46.46	4.04	0.00	0.00	1.01	2.02	2.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.08	5.06	0.42	0.00	0.42	0.42	1.26	0.42	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	20.43	6.81	1.36	0.00	0.00	0.00	0.00	0.00	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	14.62	0.64	0.64	0.64	0.64	0.00	1.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	29.15	7.29	0.81	1.62	0.81	0.81	2.43	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	37.76	6.04	3.02	0.00	0.00	0.00	1.51	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	62.81	22.84	5.71	17.13	0.00	0.00	0.00	0.00	28.55	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	48.94	13.05	0.00	0.00	0.00	6.52	6.52	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	0.00	4.75	0.00	0.00	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	0.00	12.55	0.00	0.00	0.00	0.00	37.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	17.23	7.97	1.51	1.29	1.29	0.43	0.00	0.43	0.43	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	32.40	10.97	3.14	2.09	4.70	2.09	0.00	1.57	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.68	2.00	0.67	0.00	0.67	0.00	0.00	1.33	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	9.18	0.42	0.42	0.83	0.42	0.42	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	16.92	3.04	0.57	0.57	0.57	0.19	0.00	0.38	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	3.19	0.00	0.00	0.00	0.00	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	2.04	0.68	0.00	0.68	1.36	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	1.84	0.00	0.00	3.68	0.00	0.00	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.23	4.19	0.42	1.26	2.09	0.42	0.00	0.42	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	9.30	2.79	0.46	0.46	1.16	0.70	0.00	0.93	0.23	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.97	5.94	0.81	1.62	1.08	0.27	0.00	0.54	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	18.92	8.41	0.21	1.47	1.26	0.21	0.00	0.21	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	15.39	8.44	0.50	0.99	0.00	0.99	0.00	0.00	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	13.26	6.23	0.27	0.54	1.62	0.81	0.00	0.54	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	11.56	3.85	0.00	0.23	0.91	0.23	0.00	0.45	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.86	8.00	0.98	1.14	1.14	0.49	0.16	0.00	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	10.94	8.20	0.73	0.55	1.46	1.28	0.00	0.18	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.14	3.18	0.00	1.59	0.53	1.06	0.00	0.53	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.61	4.80	0.60	0.60	4.20	1.20	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.07	10.83	0.33	0.98	2.63	0.66	0.00	0.66	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.93	4.88	1.14	0.65	0.65	0.33	0.00	1.30	0.49	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	18.70	8.64	2.29	1.59	2.65	0.53	0.00	0.00	0.18	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.25	3.52	0.70	0.00	0.70	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.45	6.44	1.38	1.84	1.38	0.46	0.00	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	12.85	6.11	0.64	1.61	1.29	1.29	0.00	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	26.56	6.90	0.69	1.03	1.72	0.34	0.00	0.69	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	5.06	0.00	2.53	2.53	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	22.50	8.02	0.45	2.67	2.23	0.45	0.00	0.00	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	14.40	3.81	0.85	0.85	1.27	0.85	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.61	3.80	0.24	1.90	0.71	0.24	0.00	0.24	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.02	7.30	0.43	1.29	0.86	0.86	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	17.33	8.00	1.00	1.67	1.33	0.33	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	30.21	4.51	0.45	2.25	1.80	0.00	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	12.30	3.17	0.79	1.59	1.98	1.19	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	15.79	8.36	0.93	4.64	0.93	3.71	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.00	4.54	0.00	0.76	0.76	0.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	19.23	5.87	1.63	1.30	0.98	0.98	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.23	5.23	1.31	2.18	0.87	0.87	0.00	0.87	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.02	4.52	3.62	0.90	1.81	0.00	0.00	0.45	0.90	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	3.53	3.53	0.00	0.88	0.00	0.00	1.76	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	20.61	7.31	0.66	0.66	0.66	1.33	0.00	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.91	10.91	1.49	2.48	0.50	1.49	0.00	0.00	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	30.24	5.74	0.77	0.77	1.15	0.38	0.00	0.00	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.13	9.38	1.21	2.72	0.60	0.30	0.00	0.60	0.91	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.52	5.97	1.33	1.33	0.88	0.66	0.00	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.91	6.78	0.00	0.00	1.36	0.68	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11	0.00	0.00	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	5.49	1.22	1.22	1.22	0.00	0.00	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	23.61	4.41	1.26	0.63	0.63	0.63	0.00	1.26	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	28.75	5.15	1.21	0.30	1.82	0.00	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	30.85	5.54	2.37	2.37	0.79	1.58	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	29.47	7.94	0.00	1.13	3.40	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	5.06	5.06	0.00	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	12.55	5.47	1.61	1.12	1.24	0.50	0.00	0.50	0.50	0.12
Myoblast, donor2	11322-117D8	21.10	12.66	3.07	1.53	2.11	1.15	0.00	0.96	0.38	0.00
Myoblast, donor3	11398-118D3	15.98	8.91	1.68	1.85	1.51	0.67	0.00	0.84	0.67	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	10.65	5.69	2.48	0.29	2.19	0.29	0.00	0.15	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	25.52	5.23	2.77	1.23	4.61	2.46	0.00	1.85	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	24.12	7.24	2.11	0.90	3.32	0.90	0.00	0.90	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	28.53	7.55	2.39	1.29	3.87	2.39	0.00	0.55	0.00	0.18
Neural stem cells, donor1	11275-116H6	6.53	22.87	1.81	3.27	1.09	3.99	0.00	0.00	0.00	0.36
Neural stem cells, donor2	11352-117H2	5.78	17.33	1.93	0.00	0.00	0.00	0.00	0.00	1.93	1.93
Neurons, donor1	11494-119E9	3.41	9.10	1.14	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	3.96	9.25	0.44	1.76	0.66	0.00	0.00	0.66	0.22	0.22
Neurons, donor3	11655-122E8	2.47	7.40	0.00	0.82	0.00	0.00	0.00	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	7.42	1.86	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	0.00	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	11.61	2.44	0.61	0.00	0.00	0.61	0.00	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	14.72	28.50	1.19	7.48	2.37	0.83	0.00	0.47	0.59	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	16.93	24.75	0.33	4.88	4.88	0.00	0.00	0.33	1.30	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	6.42	10.83	0.20	1.40	0.20	0.40	0.00	0.20	0.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	38.54	10.19	1.24	4.27	1.79	0.55	0.00	0.28	0.28	0.69
Olfactory epithelial cells, donor2	11934-125I8	28.66	9.84	1.59	1.30	2.46	0.43	0.00	0.29	0.87	0.14
Olfactory epithelial cells, donor3	11935-125I9	28.72	11.24	2.04	2.27	1.82	0.68	0.00	0.91	0.91	0.23
Olfactory epithelial cells, donor4	11936-126A1	63.50	14.41	2.82	3.21	2.92	0.19	0.00	0.68	0.29	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	8.43	6.02	0.60	1.20	0.60	0.60	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	21.48	17.44	1.49	3.83	1.06	2.98	0.00	0.64	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	11.43	13.72	0.00	0.00	2.29	1.14	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	11.17	12.41	0.00	1.86	0.62	0.62	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	7.43	15.05	1.17	1.17	1.76	0.78	0.00	0.20	0.59	0.20
Osteoblast, donor2	11354-117H4	14.05	10.53	1.40	1.40	4.21	0.00	0.00	0.70	1.40	0.70
Osteoblast, donor3	11426-118G4	8.53	8.89	0.53	1.42	1.42	0.18	0.00	0.00	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	8.51	7.41	1.52	1.10	1.18	0.93	0.00	0.25	0.25	0.34
Pericytes, donor1	11491-119E6	18.58	35.38	1.78	8.79	2.23	1.22	0.00	0.56	1.34	1.11
Pericytes, donor2	11571-120E5	13.36	24.45	0.91	5.21	1.13	0.23	0.00	0.00	0.00	1.13
Pericytes, donor3	11652-122E5	15.67	13.02	1.63	2.85	1.83	0.81	0.00	0.20	0.81	0.20
Perineurial Cells, donor1	11499-119F5	10.17	11.53	1.58	1.24	1.13	0.11	0.00	0.23	1.02	0.34
Perineurial Cells, donor2	11579-120F4	42.69	29.26	6.16	10.95	3.04	0.37	0.00	0.46	1.84	1.38
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	45.90	12.43	5.42	1.59	5.10	2.55	9.56	1.91	0.96	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	48.97	6.61	4.90	1.47	1.96	2.45	9.79	0.73	0.73	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	46.59	7.38	3.62	1.68	4.27	1.81	6.73	0.39	0.39	0.00
Placental Epithelial Cells, donor1	11278-116H9	4.78	4.54	0.48	0.24	0.96	0.00	0.00	0.24	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	9.98	11.09	0.00	1.11	3.33	0.00	0.00	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	2.94	6.28	0.39	0.98	1.18	0.00	0.00	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.92	4.11	0.00	1.58	1.27	1.27	0.00	0.00	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	15.76	9.38	0.56	2.25	0.75	1.50	0.00	0.19	1.31	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	14.10	6.27	2.22	1.31	1.57	0.39	0.00	0.52	1.04	0.26
Preadipocyte - breast, donor2	11328-117E5	15.54	11.03	0.68	1.13	1.80	0.68	0.00	0.23	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	18.33	14.07	1.39	2.13	1.49	3.41	0.00	0.75	0.53	0.43
Preadipocyte - omental, donor2	11329-117E6	19.64	7.86	0.87	1.31	1.75	0.87	0.00	0.44	2.62	0.44
Preadipocyte - omental, donor3	11403-118D8	22.35	13.47	1.29	1.86	1.29	1.72	0.00	0.43	0.86	0.14
Preadipocyte - perirenal, donor1	11469-119C2	25.59	7.87	1.97	4.92	0.00	1.97	0.00	0.00	1.97	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	14.13	12.90	0.31	2.15	1.23	2.15	0.00	0.31	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	6.37	9.21	0.71	0.53	0.35	0.71	0.00	0.35	0.18	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	10.05	9.71	0.51	2.38	0.68	1.70	0.00	0.17	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	6.43	10.34	0.93	1.12	0.47	1.58	0.00	0.47	0.00	0.09
Preadipocyte - visceral, donor2	11357-117H7	10.12	12.89	0.00	0.92	0.46	1.38	0.00	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	3.97	5.22	0.31	0.94	0.52	0.42	0.00	0.63	0.10	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	7.39	13.58	1.36	3.77	0.60	2.87	0.00	0.00	3.02	0.30
Prostate Epithelial Cells, donor2	11331-117E8	13.00	5.42	1.22	0.41	1.49	1.08	0.00	0.00	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	3.98	1.65	0.18	0.00	0.12	0.18	0.00	0.18	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	8.20	8.09	0.34	1.59	1.03	0.57	0.00	0.11	0.34	0.11
Prostate Stromal Cells, donor2	11332-117E9	8.43	6.99	1.26	0.90	0.72	0.54	0.00	0.18	0.36	0.18
Prostate Stromal Cells, donor3	11405-118E1	18.56	13.97	1.25	3.02	2.19	3.75	0.00	0.31	0.73	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.01	7.30	0.36	2.19	1.09	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	4.57	4.64	0.69	0.49	0.55	0.07	0.00	0.42	0.07	0.14
Renal Epithelial Cells, donor1	11517-119H5	3.55	11.67	0.00	2.54	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	6.40	9.25	0.71	0.71	0.71	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	5.19	10.27	0.42	0.85	0.42	0.21	0.00	0.21	0.00	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.85	14.30	0.68	2.72	0.00	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	6.20	8.09	0.13	0.67	0.81	0.13	0.00	0.27	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	5.33	7.55	0.67	0.67	0.44	0.00	0.00	0.67	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.99	14.64	0.00	2.00	1.33	0.00	0.00	0.00	0.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	7.26	12.77	0.22	2.42	0.88	0.22	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.13	11.29	0.00	1.25	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	6.38	13.04	0.28	2.77	1.94	0.00	0.00	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	2.95	5.37	0.27	0.27	0.54	0.27	0.00	0.27	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.53	5.06	0.84	0.00	0.42	0.42	0.00	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	4.05	9.26	0.00	0.96	0.58	0.00	0.00	0.19	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	2.07	4.93	1.30	0.00	0.78	0.00	0.00	0.52	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	3.98	9.10	1.42	3.41	1.42	0.85	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	8.23	0.00	1.03	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	2.26	10.29	1.00	0.25	0.00	0.25	0.00	0.25	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	27.40	9.89	1.34	2.67	0.94	2.67	2.94	0.27	2.41	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	8.04	7.15	0.00	0.89	0.00	0.89	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	7.71	3.30	0.00	0.55	0.00	0.55	0.00	1.65	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	3.48	3.48	0.58	0.00	0.58	0.58	0.00	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	7.41	5.07	0.65	0.26	1.04	0.39	0.00	0.39	0.26	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	7.25	3.57	0.89	0.40	1.29	0.00	0.00	0.20	0.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	4.91	3.57	0.45	0.33	1.34	0.11	0.00	0.11	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	8.31	3.72	1.24	0.50	0.50	0.25	0.00	0.00	0.00	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	6.53	4.43	0.58	0.35	0.82	0.12	0.00	0.12	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	9.71	2.54	1.16	0.23	0.92	0.23	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	8.21	4.52	0.96	0.41	0.82	0.41	0.00	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	8.47	3.33	0.91	1.06	0.61	0.00	0.00	0.45	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	4.30	4.30	1.25	0.18	0.72	0.36	0.00	0.36	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	10.19	5.74	0.72	0.00	1.00	0.43	0.00	0.43	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	5.79	3.54	0.75	0.43	0.86	0.00	0.00	0.21	0.11	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	5.53	4.43	1.77	0.22	1.55	0.22	0.00	0.22	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	7.46	3.82	0.96	0.38	1.15	0.00	0.00	0.38	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	6.06	4.29	0.84	0.47	1.40	0.19	0.00	0.19	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	5.64	6.39	1.13	0.19	0.19	0.00	0.00	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	10.22	5.57	1.06	0.66	1.06	0.13	0.00	0.40	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	6.42	3.70	0.58	0.29	0.19	0.10	0.00	0.29	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	5.92	2.86	0.57	0.38	0.57	0.19	0.00	0.38	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	8.86	5.34	0.53	0.53	1.07	0.21	0.00	0.32	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	7.01	3.36	0.56	0.28	1.68	0.28	0.00	0.28	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	7.35	2.39	1.03	0.51	0.68	0.34	0.00	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	10.94	3.83	0.73	0.73	0.55	0.18	0.00	0.18	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	6.99	4.29	0.98	0.25	0.74	0.00	0.00	0.37	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	6.58	2.82	0.81	0.13	0.40	0.13	0.00	0.27	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	7.55	2.83	1.42	0.24	2.12	0.24	0.00	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	6.35	2.98	1.98	0.40	0.40	0.20	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	9.35	3.27	1.17	0.47	0.94	0.23	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	9.12	4.56	2.07	0.21	0.83	0.62	0.00	0.62	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	5.31	4.20	0.22	0.22	0.66	0.44	0.00	0.44	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	6.48	1.88	0.63	0.42	1.46	0.21	0.00	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	9.82	3.63	0.67	0.27	0.81	0.27	0.00	0.13	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	7.49	3.24	1.19	0.00	0.68	0.68	0.00	0.34	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	9.45	2.89	1.16	0.58	1.54	0.00	0.00	0.00	0.19	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	8.77	4.64	1.38	0.17	1.20	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	8.09	6.17	0.69	0.69	0.96	0.55	0.00	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	9.19	4.76	0.49	0.33	1.81	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	11.42	4.09	1.02	0.68	0.68	0.17	0.00	0.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	6.51	4.14	1.04	0.00	0.89	0.30	0.00	0.00	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	8.26	4.26	1.07	0.00	1.33	0.00	0.00	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	11.75	8.02	0.55	0.41	0.97	0.00	0.00	0.55	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	8.10	2.86	0.24	0.48	1.19	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	14.91	5.44	1.61	1.21	1.01	0.60	0.00	0.40	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	7.63	6.12	0.94	0.75	1.22	0.00	0.00	0.09	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	11.18	4.54	0.70	0.70	1.75	0.70	0.00	0.00	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	4.84	3.63	0.91	0.60	0.30	0.30	0.00	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	6.36	3.92	0.24	0.98	1.10	0.12	0.00	0.37	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	9.61	5.82	1.60	1.60	1.46	0.29	0.00	0.29	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	9.13	2.43	0.00	1.22	1.22	1.22	0.00	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	4.52	5.12	0.30	0.60	1.21	0.00	0.00	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	9.05	7.01	0.23	0.68	1.36	1.13	0.00	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	10.48	5.09	0.90	0.60	1.80	1.50	0.00	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	7.56	6.38	0.24	0.47	1.30	1.06	0.00	0.35	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	7.68	5.55	1.07	0.64	0.43	1.49	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	7.81	2.40	0.00	0.60	1.20	1.20	0.00	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	6.21	14.11	0.56	2.26	0.38	0.00	0.00	0.00	0.19	0.38
Schwann Cells, donor2	11578-120F3	0.00	3.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	5.92	7.45	0.44	1.53	1.10	0.00	0.00	0.44	0.00	0.44
Sebocyte, donor1	11220-116B5	16.98	13.15	2.19	2.19	2.19	2.19	0.00	1.64	0.00	1.10
Sebocyte, donor2	11301-117B5	20.22	6.89	0.46	0.46	1.84	0.92	0.00	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	17.52	8.66	1.03	1.24	0.41	0.82	0.00	0.21	0.00	0.21
Sertoli Cells, donor1	11255-116F4	21.54	6.63	1.66	1.66	3.31	3.31	0.00	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	16.95	0.00	2.82	2.82	0.00	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	2.82	8.97	0.44	1.14	0.97	1.32	0.00	0.44	0.18	0.44
Skeletal Muscle Cells, donor2	11358-117H8	2.17	5.78	0.00	2.17	1.45	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	4.18	15.05	0.84	0.00	0.84	0.84	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	12.10	7.38	0.79	1.10	1.10	0.16	0.00	0.16	0.47	0.47
Skeletal Muscle Cells, donor5	11455-119A6	12.19	6.84	1.04	1.64	0.59	0.30	0.00	0.45	0.59	0.15
Skeletal Muscle Cells, donor6	11459-119B1	4.62	4.62	0.31	0.00	0.31	0.00	0.00	0.31	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	9.20	15.50	0.88	3.02	1.13	1.26	0.00	0.50	1.01	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.12	12.27	1.85	3.42	1.14	1.00	0.00	0.14	0.29	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	4.86	5.36	0.40	1.49	0.50	0.10	0.10	0.00	0.10	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	8.34	10.62	1.18	1.10	0.67	0.25	0.00	0.25	0.17	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	0.72	10.13	0.00	0.72	0.00	0.72	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.99	8.12	0.14	1.93	0.28	0.28	0.00	0.14	0.14	0.28
Skin - palm, donor1	10286-104F7	42.98	10.74	0.00	0.00	0.00	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	7.64	2.16	0.43	0.14	0.43	0.86	0.00	1.15	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	31.90	8.18	1.64	0.00	4.09	0.00	0.00	2.45	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.32	2.60	0.52	0.52	0.26	0.26	0.00	0.13	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	4.17	5.14	0.28	0.56	0.42	0.42	0.00	0.70	0.14	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	3.94	5.06	0.14	0.28	0.70	0.42	0.00	0.00	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	14.38	12.26	2.75	1.06	1.27	0.21	0.00	0.00	0.42	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	5.47	5.02	0.30	0.30	1.20	0.52	0.00	0.15	0.07	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	18.82	16.35	0.93	1.54	2.16	0.93	0.00	0.93	0.00	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	36.24	16.23	3.78	1.11	3.56	2.22	0.00	1.78	1.11	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	9.41	12.34	0.59	4.11	2.94	1.18	0.00	0.00	0.59	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	16.35	12.15	1.10	1.77	1.99	0.00	0.00	0.44	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	17.33	10.24	0.79	2.76	1.97	1.18	0.00	0.00	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	19.31	19.31	3.09	1.55	6.18	0.00	0.00	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	5.00	25.02	0.00	6.00	1.00	0.00	0.00	0.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	20.23	19.03	1.73	4.39	2.93	4.26	0.00	0.27	0.53	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	13.96	9.53	1.99	1.99	1.55	0.44	0.00	0.22	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.30	7.94	1.15	2.05	1.41	0.51	0.00	0.13	0.38	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	7.49	12.05	0.33	0.98	0.98	0.00	0.00	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	15.06	11.22	2.95	3.25	2.07	0.59	0.00	0.89	0.59	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	14.09	7.97	0.71	1.42	1.99	0.28	0.00	0.14	0.14	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.78	8.95	1.46	1.30	0.81	0.00	0.00	0.49	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	18.27	7.31	0.91	1.52	0.91	0.00	0.00	0.61	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.67	21.72	1.52	2.02	1.01	3.28	0.00	0.25	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	6.12	6.12	0.00	0.00	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.69	13.35	0.48	1.43	1.91	0.95	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	6.93	6.64	0.44	1.03	0.88	0.15	0.00	0.29	0.59	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	8.18	11.84	0.86	1.08	0.22	0.65	0.00	0.43	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	6.93	7.14	0.84	1.57	0.63	0.52	0.00	0.42	0.42	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	16.86	15.47	1.08	2.01	2.01	1.24	0.00	0.15	0.46	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	21.56	11.86	4.31	5.39	1.08	1.08	0.00	2.16	0.00	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.37	6.57	0.90	0.30	0.90	0.30	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.83	5.80	1.71	1.02	1.71	0.68	0.00	0.00	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	7.77	10.44	0.79	1.18	1.10	0.24	0.00	0.16	0.08	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	32.21	15.60	1.91	2.21	1.71	10.06	0.00	1.21	0.40	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	42.10	13.43	2.05	4.32	4.10	1.37	0.00	0.23	1.59	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	31.40	15.70	4.23	4.83	2.42	1.21	0.00	0.00	1.21	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	6.36	7.68	0.53	0.53	0.26	0.00	0.00	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	12.92	12.52	0.27	1.46	0.40	0.93	0.00	0.53	0.27	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	14.15	11.90	1.00	2.38	1.63	1.88	0.00	0.50	0.38	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	11.67	8.88	0.25	3.04	0.51	0.51	0.00	0.51	1.27	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.04	15.68	1.66	2.71	1.51	1.81	0.00	0.15	0.15	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	16.50	12.00	0.75	3.00	0.75	3.00	0.00	1.50	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	19.38	0.00	2.58	1.29	1.29	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	27.90	33.95	4.19	5.58	4.65	1.40	0.00	1.40	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	26.76	17.67	4.04	2.52	2.52	2.02	0.00	0.50	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	42.31	11.28	1.88	3.45	3.45	2.51	0.00	0.94	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	11.50	7.96	1.77	0.88	1.47	0.29	0.00	0.59	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	2.75	3.75	0.58	0.33	0.25	0.00	0.00	0.42	0.08	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.54	6.54	1.40	1.87	0.47	0.00	0.00	0.00	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	17.70	10.36	2.01	2.59	2.01	1.30	0.00	0.00	0.43	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.47	5.35	1.78	0.76	1.02	0.76	0.51	0.25	1.27	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.03	7.15	0.94	2.07	0.94	0.00	0.00	0.19	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	6.71	6.85	0.42	0.98	0.70	0.00	0.00	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	6.70	6.62	0.75	1.93	0.42	0.17	0.00	0.34	0.00	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.29	8.57	0.95	0.95	1.43	0.00	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	20.06	10.52	1.71	2.45	2.20	1.47	0.00	0.24	0.49	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	19.00	12.59	1.33	1.99	0.88	1.55	0.00	0.66	0.44	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	5.27	7.31	0.88	0.29	0.59	0.00	0.00	0.00	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	22.74	10.50	0.58	1.36	2.72	1.55	0.00	0.58	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	22.21	7.40	0.26	1.06	1.32	0.53	0.00	0.53	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	23.80	5.95	0.37	0.37	0.74	1.86	0.00	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	36.29	7.91	1.44	2.16	2.87	1.08	0.00	1.44	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	13.34	3.12	0.85	1.14	1.99	1.14	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	7.48	6.30	1.18	0.00	1.18	0.00	0.00	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	14.48	7.11	0.76	0.76	0.76	1.02	0.00	0.76	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	18.37	13.18	1.20	2.00	2.00	2.80	0.00	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	12.54	9.61	0.42	0.42	1.25	0.00	0.00	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	8.71	7.33	0.92	0.00	0.46	0.92	0.00	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	28.28	22.05	2.69	3.37	3.03	1.85	0.00	0.50	0.84	0.67
Synoviocyte, donor2	11368-117I9	12.57	9.55	0.67	1.68	1.17	1.84	0.00	0.00	0.50	0.17
Synoviocyte, donor3	11440-118H9	11.84	5.59	0.45	0.89	0.89	0.89	0.00	0.45	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	3.93	6.43	0.00	1.07	1.79	0.00	0.00	0.00	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	27.75	9.91	0.00	0.00	1.98	0.00	0.00	0.00	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	5.79	13.20	0.46	1.62	0.69	0.23	0.00	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	3.15	4.95	0.65	1.00	0.36	0.22	0.00	0.07	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	4.25	3.09	1.16	0.77	0.39	0.39	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.86	5.15	1.15	1.72	1.15	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	30.39	10.95	2.83	0.74	1.48	1.85	2.71	0.37	2.46	0.00
Urethra, donor2	10319-105A4	46.76	3.60	0.00	0.00	0.00	1.80	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	7.97	5.05	2.13	0.00	0.80	0.27	0.00	0.53	0.27	0.53
Urothelial Cells, donor2	11600-120H7	8.01	4.01	1.60	0.80	0.40	0.00	0.00	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	11.92	4.58	0.69	0.23	0.46	0.46	0.00	0.69	0.00	0.00
Urothelial cells, donor0	11216-116B1	8.02	8.25	0.89	1.34	2.45	0.00	0.00	0.22	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	22.24	4.45	3.56	0.00	0.89	0.00	11.57	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	30.02	4.29	1.43	0.00	1.43	0.00	5.72	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	19.85	2.74	2.74	0.00	0.00	0.00	0.00	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	14.46	3.44	3.44	0.34	0.69	0.34	0.00	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	13.36	4.07	1.74	0.00	1.74	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	18.74	5.21	3.12	0.00	3.12	0.00	8.33	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	28.45	4.59	1.84	0.00	0.92	0.00	7.34	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	18.26	3.65	2.74	0.91	0.91	0.00	3.65	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	3.82	15.42	2.34	7.53	1.85	0.49	0.00	0.00	0.62	0.37
Wilms' tumor cell line:HFWT	10597-108E3	8.80	7.04	0.00	0.88	0.88	0.00	0.00	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	3.35	2.51	0.84	0.00	0.28	0.00	0.00	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	33.06	12.40	2.07	0.00	2.07	0.00	2.07	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	7.90	2.04	1.53	0.51	2.04	0.25	1.02	0.25	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	2.79	5.11	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	3.80	2.85	0.59	0.00	0.71	0.00	0.00	0.47	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	7.07	8.44	1.36	0.27	0.54	0.00	0.00	0.27	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.56	1.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	3.60	1.48	0.21	0.00	0.21	0.00	0.00	0.21	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	6.81	2.18	0.82	0.54	0.27	0.27	0.00	0.54	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	2.20	1.76	1.32	0.00	0.88	0.44	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	9.39	2.04	0.82	0.41	0.82	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	36.11	6.99	3.11	4.27	4.27	0.39	1.94	0.39	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	2.02	2.39	0.00	0.00	0.00	0.18	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	0.00	0.00	0.00	0.00	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	6.04	1.39	0.23	0.00	0.70	0.23	0.00	0.70	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	18.64	5.18	0.78	0.26	0.26	0.26	0.26	0.26	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	9.35	2.92	1.46	0.58	0.00	0.29	0.58	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	7.90	3.25	0.46	0.00	1.39	0.46	0.93	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	5.76	3.29	0.82	0.41	0.82	0.82	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	2.76	1.84	0.31	0.00	0.61	0.31	0.61	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	8.53	3.41	1.28	0.43	0.85	0.00	1.71	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	7.89	3.03	0.61	0.00	0.00	0.00	1.21	0.30	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	7.94	1.93	0.72	0.24	0.48	0.48	1.93	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	6.01	1.78	0.89	0.00	1.11	0.67	1.34	0.45	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	10.67	2.00	0.00	0.33	0.33	0.67	0.00	0.67	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	5.57	3.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1.13	0.38	0.00	0.00	0.00	0.00	0.38	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	8.29	2.62	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	7.50	0.00	1.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	15.78	2.12	1.88	0.24	1.65	0.94	0.00	0.47	2.12	0.00
adipose tissue, adult, pool1	10010-101C1	37.69	11.48	2.64	1.09	2.48	4.34	1.71	0.62	0.93	0.00
adipose, donor1	10184-103D4	1.76	4.10	0.00	2.35	1.17	3.52	0.00	0.00	0.59	1.17
adipose, donor2	10185-103D5	10.14	18.65	2.43	13.38	0.41	4.87	0.00	1.22	0.81	1.22
adipose, donor3	10186-103D6	8.99	17.70	0.82	6.81	0.82	2.45	0.00	0.27	1.63	0.54
adipose, donor4	10187-103D7	4.33	8.67	0.00	3.47	0.00	0.87	0.00	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	36.61	5.37	2.68	0.63	1.10	0.63	0.00	1.74	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	25.46	7.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	13.21	3.74	1.47	0.13	0.27	0.53	0.13	0.13	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	7.86	2.50	0.36	1.07	0.36	1.07	0.00	0.71	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	12.29	4.64	0.93	0.46	0.46	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	10.82	7.78	0.34	0.68	1.35	0.34	0.34	0.00	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	20.03	5.30	1.18	0.29	0.00	0.59	0.00	0.59	0.29	0.00
amygdala - adult, donor10196	10167-103B5	39.13	10.67	1.19	1.19	2.37	0.00	0.00	3.56	0.00	0.00
amygdala, adult, donor10252	10151-102I7	32.04	9.94	3.65	1.22	1.62	0.20	0.41	1.82	0.61	0.00
amygdala, newborn, donor10223	10360-105E9	14.52	8.71	0.97	1.61	0.65	0.65	0.00	0.65	0.97	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	7.89	7.51	2.42	1.27	1.02	1.40	0.00	0.00	0.25	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	3.97	2.43	0.66	0.22	0.44	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	7.01	7.68	0.33	0.67	0.33	0.67	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	39.03	8.24	1.96	1.77	2.16	0.98	0.20	0.20	1.37	0.00
appendix, adult	10189-103D9	33.77	8.15	2.33	0.78	0.39	2.33	3.49	0.78	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	20.29	15.48	2.41	10.66	3.10	2.41	0.00	1.03	0.69	0.69
artery, adult	10190-103E1	24.46	10.87	1.36	0.00	0.00	2.72	0.00	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	6.52	12.31	0.87	1.30	1.45	1.01	0.00	0.29	0.29	0.43
b cell line:RPMI1788	10427-106D4	8.03	3.27	2.08	0.45	3.27	0.00	0.30	0.59	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	27.47	9.99	1.11	2.50	2.50	1.39	0.00	0.55	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	3.87	8.34	1.09	0.79	1.79	1.59	0.00	0.20	0.00	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	2.34	0.17	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	17.90	4.47	0.56	0.56	1.12	0.56	4.47	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	42.80	7.39	1.74	2.17	1.52	2.39	0.54	0.33	0.33	0.22
blood, adult, pool1	10053-101G8	19.93	4.43	0.00	0.00	2.21	2.21	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	12.85	2.57	1.71	0.00	0.00	0.00	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	76.26	9.45	6.07	2.70	2.70	0.67	2.02	0.00	1.35	0.00
brain, adult, donor1	10084-102B3	44.08	10.25	2.05	1.03	1.03	4.10	0.00	4.10	0.00	1.03
brain, adult, pool1	10012-101C3	34.86	11.69	2.67	1.00	1.34	1.00	0.22	2.56	0.45	0.22
brain, fetal, pool1	10085-102B4	13.36	8.01	0.00	2.67	0.00	2.67	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	17.51	3.63	2.97	0.99	0.99	0.66	0.00	0.00	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	21.22	8.86	2.62	1.50	0.62	0.25	0.00	0.62	0.25	0.50
breast, adult, donor1	10080-102A8	53.67	10.10	0.63	1.26	1.26	1.89	0.63	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	2.16	3.81	0.76	0.38	0.38	0.25	0.00	0.38	0.13	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	4.02	6.49	0.62	0.62	2.78	0.62	0.00	0.62	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	12.43	21.18	1.84	0.92	1.84	0.46	0.00	1.84	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.04	4.36	3.15	0.48	1.21	0.48	0.00	0.24	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	0.94	0.94	0.00	0.47	0.94	0.00	0.00	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	13.34	13.02	1.20	1.86	1.53	0.66	0.00	0.55	0.11	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	3.80	4.12	0.63	0.32	0.32	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	4.26	3.19	0.27	0.53	0.53	0.80	0.00	0.27	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	33.39	8.06	1.15	1.15	2.30	1.15	0.00	5.76	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	32.29	8.37	3.01	0.84	1.17	0.50	0.50	4.18	0.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	25.98	4.58	4.58	0.76	1.53	0.76	0.00	4.58	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	20.51	10.25	2.93	2.56	1.46	0.37	0.00	4.03	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	58.27	5.83	0.00	0.00	2.91	5.83	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	37.36	12.38	7.05	0.43	2.35	1.92	0.21	1.92	0.85	0.43
cerebellum, adult, pool1	10083-102B2	21.39	6.90	2.07	2.07	1.03	1.38	0.00	1.38	1.38	0.00
cerebellum, newborn, donor10223	10357-105E6	47.33	7.47	4.15	1.66	8.30	3.32	0.00	5.81	1.66	0.83
cerebral meninges, adult	10188-103D8	16.89	9.83	2.27	0.76	1.26	1.01	0.00	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	14.62	0.73	0.73	0.00	1.46	2.92	1.46	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	6.04	2.16	0.86	0.58	0.72	0.00	0.00	0.14	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	9.11	4.31	0.83	0.66	0.50	0.17	0.00	0.33	0.33	0.17
cervix, adult, pool1	10013-101C4	35.49	11.65	2.94	2.94	2.10	4.51	0.00	1.15	0.42	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	12.26	2.51	1.95	0.14	0.56	0.98	0.00	0.28	0.14	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	0.00	0.00	1.31	0.00	1.31	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	18.77	19.64	4.97	3.11	2.98	4.97	0.00	0.50	0.25	0.50
choriocarcinoma cell line:SCH	10785-110H2	28.46	9.98	7.15	2.83	2.34	1.97	0.00	0.12	0.99	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	15.18	9.01	2.13	0.00	2.37	0.71	0.00	0.24	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	17.10	5.41	3.42	0.57	0.85	0.28	0.00	0.28	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	17.30	21.08	1.49	3.28	1.79	3.38	0.00	0.20	0.50	0.30
chorionic membrane cells, donor3	12240-129G8	25.83	3.85	2.20	1.10	2.75	0.00	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	4.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	7.88	2.31	1.73	0.38	0.58	0.00	0.00	0.19	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	6.76	1.90	0.84	0.00	0.63	0.84	0.00	0.00	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	10.02	4.37	0.51	0.26	0.26	0.26	0.00	0.26	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	11.37	2.66	0.24	0.24	1.69	0.24	0.00	0.00	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	10.38	8.14	1.22	0.61	1.43	0.20	0.00	0.41	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	6.18	3.53	0.88	0.59	0.59	0.00	0.00	0.00	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	13.55	5.99	1.82	0.78	0.78	1.56	0.00	0.26	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.00	3.20	0.69	0.23	0.91	0.46	0.00	0.91	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	5.73	2.60	2.08	0.52	0.87	0.52	0.00	0.17	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	13.73	15.56	2.20	2.38	1.10	1.10	0.00	0.73	5.31	0.18
colon carcinoma cell line:COLO-320	10420-106C6	4.56	6.84	0.76	1.52	0.38	0.00	0.00	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	57.12	5.95	4.76	0.00	4.76	2.38	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	47.24	11.52	1.76	3.64	1.29	11.87	0.59	0.47	7.64	0.35
colon, fetal, donor1	10070-101I7	61.80	8.65	1.24	1.24	2.47	3.71	0.62	0.62	4.33	0.00
common myeloid progenitor CMP, donor1	12130-128D6	4.58	13.75	0.00	4.58	0.00	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	3.82	3.40	0.85	0.00	0.42	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	2.41	4.38	0.45	0.15	0.15	0.91	0.00	0.00	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	1.83	3.24	0.85	0.14	0.00	0.14	0.00	0.00	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	126.15	10.95	4.98	1.77	1.88	3.21	0.55	2.43	0.88	0.33
cruciate ligament, donor2	10295-104G7	50.25	4.86	0.00	1.62	1.62	0.81	0.81	1.62	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	24.88	8.83	3.21	1.61	4.82	1.61	0.00	0.80	0.00	0.80
diencephalon, adult	10193-103E4	35.52	6.24	1.20	0.72	0.48	0.72	0.00	1.68	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	4.36	3.21	1.61	0.23	0.92	0.23	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	3.59	6.92	0.77	0.26	3.33	0.51	0.00	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	5.78	8.18	0.24	2.17	1.20	0.24	0.00	0.24	0.00	0.24
ductus deferens, adult	10196-103E7	58.31	13.95	2.99	2.49	0.50	1.50	0.50	0.50	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	56.17	4.32	0.00	5.76	1.44	4.32	0.00	1.44	10.08	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	50.02	12.51	4.41	2.94	2.21	3.68	0.00	0.00	13.98	0.74
dura mater, adult, donor1	10041-101F5	46.83	24.61	4.96	7.43	3.47	3.06	2.15	0.99	1.65	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	10.66	18.88	0.22	3.33	2.22	3.78	0.00	0.44	0.00	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	2.58	5.73	0.43	1.00	0.29	0.72	0.00	0.00	0.43	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	1.85	3.08	0.00	0.62	0.62	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	3.33	3.03	0.61	0.30	0.91	0.30	0.00	0.30	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	2.78	4.63	0.00	0.00	0.62	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	0.00	3.94	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	2.68	4.36	0.00	0.67	1.01	1.01	0.00	0.34	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	9.42	4.17	1.63	0.18	1.27	0.36	0.00	0.00	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	5.47	3.06	0.64	0.16	0.48	0.32	0.00	0.32	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	4.67	2.45	0.78	0.11	0.44	0.22	0.00	0.11	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	2.86	2.31	0.77	0.00	0.55	0.11	0.00	0.00	0.00	0.00
epididymis, adult	10197-103E8	32.02	15.49	1.47	2.72	0.42	6.07	0.00	0.63	0.84	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	5.68	6.03	1.60	0.35	0.00	0.00	0.00	0.53	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	2.75	7.08	0.79	0.00	0.79	1.18	0.00	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	3.54	4.72	1.05	0.66	0.92	0.00	0.00	0.13	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	3.84	4.92	0.89	0.79	0.89	0.20	0.00	0.10	0.00	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	3.47	4.59	1.01	0.67	0.90	0.00	0.00	0.22	0.00	0.00
esophagus, adult, pool1	10015-101C6	19.86	4.25	1.17	0.85	1.06	1.17	0.21	0.21	0.32	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	6.64	26.30	1.25	7.39	2.50	5.13	0.00	0.25	10.39	0.88
eye - muscle inferior rectus, donor1	10272-104E2	86.92	7.24	7.24	4.83	0.00	0.00	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	8.42	4.21	2.10	2.10	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	31.25	4.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	35.54	4.59	2.29	2.29	2.29	2.29	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	34.98	1.46	0.00	0.00	2.91	1.46	0.00	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	23.90	8.64	3.05	1.02	0.76	0.51	0.00	0.51	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	2.82	1.41	0.38	0.26	0.13	0.13	0.00	0.00	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	6.65	7.83	0.71	1.19	1.90	0.71	0.00	0.00	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	36.03	17.92	3.00	0.94	1.88	2.16	0.09	3.38	0.75	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	19.52	11.71	1.80	1.50	1.80	1.50	0.00	0.90	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	23.68	7.04	2.19	0.46	1.65	0.09	0.00	1.37	0.09	0.37
gall bladder, adult	10198-103E9	40.32	10.86	1.93	2.66	1.21	3.62	0.24	0.24	0.72	0.24
gamma delta positive T cells, donor1	11937-126A2	10.20	4.29	2.15	0.00	1.61	1.61	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	16.43	4.11	1.49	0.37	1.87	2.24	5.60	1.12	1.49	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	1.69	7.39	1.06	1.69	0.84	0.21	0.00	0.00	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	10.83	11.80	2.71	2.51	1.55	0.97	0.00	0.19	0.19	0.39
gastric cancer cell line:AZ521	10549-107H9	4.26	7.87	1.64	1.48	0.82	0.16	0.00	0.66	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	19.22	7.32	4.58	0.00	9.15	2.75	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	24.67	11.19	1.37	2.51	2.06	2.74	0.00	0.23	0.91	0.23
giant cell carcinoma cell line:LU65	10487-107B1	0.46	0.23	0.00	0.00	0.11	0.00	0.00	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	3.50	9.38	1.26	0.56	0.84	0.14	0.00	0.28	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	1.50	0.50	1.00	0.00	0.25	0.25	0.00	0.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	7.07	4.12	1.37	0.84	1.27	0.21	0.00	0.21	0.00	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	7.16	3.51	1.26	1.54	0.56	0.14	0.00	0.14	0.14	0.56
glioblastoma cell line:T98G	10485-107A8	7.40	12.25	1.32	1.21	0.77	0.11	0.00	0.11	0.00	0.66
glioma cell line:GI-1	10413-106B8	2.93	5.86	0.00	0.00	0.88	0.59	0.00	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	95.49	2.19	0.00	0.00	1.46	1.46	0.00	2.92	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	62.73	6.83	3.17	0.24	0.73	0.24	0.00	1.22	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	69.83	4.11	2.74	0.00	1.37	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	44.23	4.26	1.07	1.60	1.60	2.66	0.00	1.60	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	12.24	19.58	0.00	2.45	0.00	0.00	0.00	0.00	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	17.28	5.44	1.28	0.96	1.28	0.64	0.00	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	1.84	4.59	0.46	2.30	0.46	0.00	0.00	0.46	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	2.74	2.74	0.00	1.83	0.00	0.91	0.00	0.91	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	3.22	5.15	0.00	1.93	1.29	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	2.87	2.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	0.00	2.06	0.69	0.69	1.37	0.00	0.00	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	33.10	3.31	1.10	1.10	1.10	2.21	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	9.48	4.88	2.01	0.00	0.86	0.86	0.00	0.57	0.00	0.00
heart - mitral valve, adult	10205-103F7	30.20	8.37	1.79	2.69	1.20	2.09	0.00	0.60	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	31.38	5.49	1.57	1.31	0.52	1.05	0.26	1.05	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	23.31	5.83	1.67	3.33	0.00	0.83	1.67	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	27.14	5.31	1.84	1.22	1.22	1.63	0.20	0.20	0.41	0.00
heart, adult, diseased, donor1	10051-101G6	19.59	7.24	1.28	1.70	1.28	2.13	0.43	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	9.43	5.98	1.15	1.38	0.92	0.00	0.23	0.00	0.69	0.23
heart, fetal, pool1	10046-101G1	19.20	17.25	2.67	4.31	3.39	0.72	0.10	0.82	1.03	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	38.26	9.56	1.54	0.93	3.70	0.31	0.00	0.00	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	2.38	4.76	0.00	0.00	1.19	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	9.28	6.63	0.55	1.55	0.22	0.44	0.00	0.44	4.09	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	7.04	6.19	1.09	1.21	0.49	0.61	0.00	0.24	4.61	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	8.69	5.96	1.72	2.22	0.61	0.81	0.00	0.20	4.65	0.30
hepatoma cell line:Li-7	10484-107A7	2.45	2.89	0.44	0.44	0.33	0.33	0.00	0.11	0.22	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	8.44	5.53	1.11	0.60	1.61	0.00	0.00	0.20	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	48.26	5.68	3.79	0.00	0.00	0.00	0.00	2.84	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	35.11	8.57	3.27	0.41	2.04	0.82	0.20	1.22	0.41	0.20
hippocampus, adult, donor10258	10374-105G5	28.38	2.99	0.50	0.50	2.49	1.99	0.00	5.48	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	22.91	17.62	1.41	2.82	3.52	1.41	0.35	2.11	1.41	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	2.44	4.88	0.00	0.61	0.61	0.61	0.00	0.00	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	3.14	5.69	0.39	1.57	0.98	0.59	0.00	0.00	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	2.54	4.32	0.51	1.52	1.78	0.25	0.00	0.00	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	6.20	14.66	0.00	5.07	1.13	3.95	0.00	0.00	1.13	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3.61	11.36	0.26	4.91	1.03	3.36	0.00	0.00	1.03	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	2.66	18.22	0.38	4.56	0.38	4.93	0.00	0.00	0.38	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	6.13	12.55	1.17	4.38	0.88	2.34	0.00	0.00	0.00	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	6.46	12.06	0.86	3.02	1.29	1.51	0.00	0.65	0.43	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.01	16.68	0.00	6.26	0.42	2.92	0.00	0.42	1.25	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	2.37	8.76	0.71	2.84	0.24	1.89	0.00	0.24	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	4.50	12.21	1.45	2.09	0.96	1.93	0.00	0.00	0.80	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	5.39	16.83	1.35	4.04	0.67	1.35	0.00	0.00	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	4.07	3.44	0.31	1.41	0.63	1.25	0.00	0.63	0.31	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	6.88	3.93	0.00	2.46	0.49	2.46	0.00	0.00	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	2.62	2.62	0.00	1.75	0.00	0.87	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	4.39	21.00	0.00	8.02	1.15	5.73	0.00	0.19	0.57	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	4.36	16.57	0.87	5.23	1.31	4.80	0.00	0.00	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	2.00	12.49	0.50	17.49	0.50	4.50	0.00	0.00	0.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.97	16.39	1.51	8.10	0.57	3.01	0.00	0.19	1.32	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.00	14.10	0.45	8.64	0.91	0.91	0.00	0.91	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	6.89	17.23	1.25	9.71	2.51	3.45	0.00	1.57	1.88	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	5.06	15.02	2.61	7.68	2.12	2.12	0.00	0.49	1.47	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	6.97	16.84	0.87	4.94	0.87	3.19	0.00	0.58	0.58	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	4.78	23.91	1.20	10.76	2.09	1.20	0.00	0.00	0.90	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	4.25	5.17	0.37	2.03	0.37	1.48	0.00	0.00	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	4.85	3.42	0.57	1.71	0.29	1.71	0.00	0.00	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	5.72	4.08	1.22	1.22	0.82	1.22	0.00	0.00	0.00	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	3.17	17.60	0.35	4.93	0.70	2.82	0.00	0.00	1.06	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	5.70	15.52	0.63	4.43	0.95	2.53	0.00	0.00	2.22	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	6.66	17.55	0.91	8.47	0.91	2.72	0.00	0.30	1.82	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	11.89	13.96	1.03	2.07	1.03	1.03	0.00	1.03	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	11.29	15.28	0.66	3.98	1.33	3.98	0.00	1.33	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	6.16	13.08	1.54	6.41	1.03	2.05	0.00	1.28	0.26	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	7.16	11.50	1.79	5.37	0.77	2.30	0.00	0.51	1.28	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	6.06	15.14	0.76	6.82	0.76	3.79	0.00	0.00	3.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.07	19.16	1.34	3.36	2.02	4.37	0.00	0.00	0.00	2.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	3.14	5.31	0.24	0.72	0.72	1.21	0.00	0.24	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	2.67	4.46	0.89	1.34	0.45	3.57	0.00	1.34	1.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	4.88	7.32	0.49	2.44	1.95	3.90	0.00	0.49	1.46	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	5.20	11.00	1.22	7.03	0.92	1.53	0.00	0.31	0.31	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	6.51	0.00	0.00	0.00	6.51	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	3.97	11.91	0.33	3.64	0.00	4.96	0.00	0.00	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	4.93	17.51	1.64	4.38	1.64	1.64	0.00	1.09	0.55	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	8.69	12.30	1.45	5.43	2.53	1.45	0.00	0.36	1.45	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	4.27	11.39	1.42	2.14	1.07	1.42	0.00	0.00	0.36	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	3.58	8.35	0.00	1.19	1.19	4.77	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	3.79	17.33	0.95	7.58	2.03	3.39	0.00	0.41	0.54	1.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	5.93	15.09	2.16	4.58	0.54	1.08	0.00	0.00	1.62	0.54
immature langerhans cells, donor1	11904-125F5	16.47	2.18	1.70	0.00	0.97	3.63	0.00	0.24	0.24	0.00
immature langerhans cells, donor2	11905-125F6	41.98	6.34	1.58	2.38	1.58	7.92	0.00	0.79	1.58	0.00
insula, adult, pool1	10039-101F3	35.77	18.74	3.97	1.70	1.51	2.27	0.09	5.30	0.57	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	6.50	3.58	0.65	0.33	0.33	0.65	0.00	0.65	0.00	0.00
kidney, adult, pool1	10017-101C8	12.42	7.51	1.70	1.40	0.70	1.90	0.10	0.50	0.40	0.20
kidney, fetal, pool1	10045-101F9	26.60	20.37	2.83	4.31	2.76	0.78	0.14	0.85	1.49	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	3.69	7.95	0.00	0.99	1.14	0.57	0.00	0.00	0.57	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	3.18	3.04	0.55	0.41	1.11	0.00	0.00	0.14	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	2.39	1.10	0.92	0.18	0.37	0.00	0.00	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	28.88	3.81	0.00	1.63	0.00	0.00	1.09	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	26.80	5.06	2.53	0.51	0.51	0.51	0.51	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	21.62	11.77	1.37	1.64	1.09	0.27	0.00	0.27	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	25.51	16.88	3.23	2.16	1.80	2.16	0.00	0.72	1.08	1.08
leiomyoma cell line:15242A	10570-108B3	13.59	4.89	1.09	0.54	1.09	3.80	0.00	0.54	1.09	0.00
leiomyoma cell line:15425	10571-108B4	18.70	7.77	1.21	1.46	1.21	1.21	0.00	0.73	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	6.35	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	6.27	5.23	1.05	1.05	0.00	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	7.20	1.53	0.12	0.00	0.71	0.47	0.00	0.00	0.12	0.12
liposarcoma cell line:KMLS-1	10782-110G8	20.78	10.93	1.25	1.72	2.03	0.31	0.00	0.31	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	12.06	9.14	1.34	0.85	2.92	0.49	0.00	0.49	0.37	0.24
liver, adult, pool1	10018-101C9	34.03	14.26	3.24	2.11	1.62	3.73	0.65	0.65	4.70	0.00
liver, fetal, pool1	10086-102B5	36.69	6.58	0.00	0.94	0.94	3.76	0.94	0.94	3.76	0.00
locus coeruleus - adult, donor10196	10182-103D2	72.62	5.25	2.92	0.58	0.87	0.87	0.15	1.60	0.44	0.29
locus coeruleus, adult, donor10252	10165-103B3	49.09	4.61	2.03	0.55	1.11	0.74	0.00	1.11	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	51.91	5.92	2.54	1.41	1.97	0.56	0.28	1.69	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	19.35	8.41	0.00	1.26	0.84	0.00	0.84	0.84	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	2.49	2.77	0.42	0.00	0.28	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	4.83	6.89	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	9.23	2.50	0.26	0.40	0.53	0.53	0.00	0.13	0.00	0.13
lung, adult, pool1	10019-101D1	31.42	11.10	1.65	1.42	1.65	3.43	3.78	0.47	0.83	0.71
lung, fetal, donor1	10068-101I5	38.82	18.27	3.14	3.71	2.00	1.14	0.86	2.57	1.14	3.14
lung, right lower lobe, adult, donor1	10075-102A3	110.89	13.29	3.21	0.92	0.46	5.96	2.75	2.29	0.92	0.92
lymph node, adult, donor1	10077-102A5	39.76	12.78	3.31	0.47	5.68	1.89	1.89	0.00	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	3.51	3.29	0.66	0.22	1.10	0.44	0.00	0.00	0.44	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.15	11.47	2.26	1.06	4.83	1.51	0.60	0.15	0.30	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	3.40	0.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	38.18	17.76	2.22	4.00	1.33	3.11	0.00	1.33	2.66	0.44
mature adipocyte, donor2	12232-129F9	44.83	12.04	0.83	1.25	1.45	1.66	0.42	1.04	1.87	0.62
mature adipocyte, donor3	12233-129G1	61.87	10.43	1.19	3.79	1.66	3.56	0.47	0.71	1.90	0.00
mature adipocyte, donor4	12234-129G2	24.74	8.16	1.58	2.37	0.53	0.53	0.00	0.53	1.84	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	11.67	9.53	3.34	0.24	2.38	1.43	0.00	0.71	0.24	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	22.56	4.51	2.26	1.13	1.13	1.13	0.00	4.51	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	35.68	10.11	3.31	1.29	2.21	1.84	0.00	2.76	0.55	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	27.96	7.62	0.95	0.00	2.22	0.64	0.00	2.54	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	8.53	9.38	0.00	0.85	2.56	1.28	0.43	1.28	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	28.18	10.97	2.19	0.68	0.51	1.18	0.00	3.04	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	40.11	10.40	3.40	0.21	2.33	0.64	0.00	2.33	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	3.85	1.93	0.00	1.93	1.93	0.00	3.85	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	16.87	13.64	2.15	1.08	1.08	0.72	0.00	1.08	0.72	0.36
medulla oblongata - adult, donor10196	10174-103C3	58.41	5.84	1.95	1.30	1.30	0.65	0.00	2.60	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	50.31	5.88	2.63	0.77	0.31	0.93	0.46	2.17	0.00	0.15
medulla oblongata, adult, pool1	10038-101F2	78.93	9.96	5.71	1.55	1.55	1.14	0.24	2.86	0.49	0.65
medulla oblongata, newborn, donor10223	10361-105F1	28.82	6.25	1.04	0.69	1.74	1.04	0.35	1.04	0.00	1.04
medulloblastoma cell line:D283 Med	10838-111E1	5.09	10.41	1.55	3.10	1.55	0.00	0.00	0.22	0.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	1.71	0.73	0.49	0.49	0.61	0.24	0.00	0.12	0.12	0.12
melanoma cell line:COLO 679	10514-107E1	2.01	4.02	0.14	0.57	0.43	0.29	0.00	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	1.09	1.36	0.27	0.00	0.00	0.81	0.00	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	3.98	4.52	0.18	0.54	0.72	0.18	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	2.64	3.52	0.00	0.00	0.88	0.88	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	6.48	5.70	1.30	1.56	0.52	0.26	0.00	0.52	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	7.36	6.29	0.31	1.38	0.31	0.46	0.00	0.31	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.09	5.64	0.91	0.55	0.91	0.36	0.00	0.18	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	5.80	4.14	0.83	0.83	0.41	0.00	0.00	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	6.74	5.48	0.28	0.70	0.56	0.14	0.00	0.14	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.09	8.67	0.19	1.16	0.77	0.00	0.00	0.00	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.11	2.78	0.00	0.00	1.39	0.69	0.00	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.38	5.15	0.51	0.34	0.69	0.17	0.00	0.34	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	8.40	3.68	0.58	0.81	0.69	0.69	0.00	0.12	0.35	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	9.15	9.95	0.66	1.46	1.06	0.27	0.00	0.13	0.27	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	10.94	6.75	0.68	1.22	0.27	0.27	0.00	0.41	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	6.12	4.84	0.71	0.43	0.28	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	5.27	5.27	0.00	0.33	0.00	0.66	0.00	0.66	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	5.53	7.75	0.55	0.97	0.69	0.14	0.00	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	6.98	8.03	0.35	1.05	1.05	0.00	0.00	1.05	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	6.53	5.72	0.20	0.82	0.61	0.41	0.00	0.20	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	9.71	9.35	1.08	1.44	1.44	1.08	0.00	0.36	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.76	6.52	0.41	0.93	1.14	0.21	0.00	0.10	0.00	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	10.72	4.56	0.68	0.46	1.60	0.91	0.00	0.46	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	5.03	3.78	0.00	1.26	1.68	0.42	0.00	0.00	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	10.76	8.07	1.20	1.05	1.49	0.90	0.00	0.15	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	3.15	5.51	0.35	0.53	0.26	0.18	0.00	0.00	0.00	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	3.31	7.73	0.00	1.84	0.00	0.37	0.00	0.37	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	13.45	8.87	0.57	0.86	0.57	0.86	0.00	0.86	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	4.21	7.58	1.68	0.84	0.42	0.42	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.05	7.76	0.00	2.28	0.91	1.83	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	11.25	11.00	1.02	1.02	1.28	1.53	0.00	0.51	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	12.56	10.47	1.57	2.09	0.52	1.57	0.00	0.52	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.78	11.09	1.23	1.54	1.54	1.85	0.00	0.62	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.71	7.30	1.65	1.88	0.94	1.18	0.00	0.00	0.47	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	14.89	12.18	0.68	4.06	1.02	1.35	0.00	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	16.50	11.79	0.79	0.79	1.57	0.39	0.00	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	12.51	8.34	0.93	0.93	0.93	0.00	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	11.83	10.38	1.44	1.15	0.58	0.87	0.00	0.00	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	14.28	7.81	0.22	1.78	1.56	0.89	0.00	0.22	0.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	15.62	9.13	2.16	1.44	1.44	1.20	0.00	0.48	0.48	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	26.40	14.67	0.73	1.47	1.47	2.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	13.76	11.75	2.01	1.34	0.67	0.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.92	10.64	1.64	2.05	2.05	0.82	0.00	1.23	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.75	10.74	1.29	3.44	3.01	0.00	0.00	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	8.20	0.00	2.73	0.00	2.73	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	0.00	0.00	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	11.04	7.47	0.65	0.65	0.65	1.30	0.00	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	7.27	0.00	2.91	1.45	2.91	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	17.06	8.53	1.07	2.67	2.67	1.60	0.00	0.53	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.00	7.36	1.64	3.27	1.64	0.00	0.00	0.00	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.83	9.72	0.39	3.11	0.78	0.39	0.00	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	4.20	0.00	4.20	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	9.93	7.95	0.00	2.98	1.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.71	7.71	0.59	0.59	1.19	1.19	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	17.06	12.18	0.00	2.44	2.44	1.22	0.00	1.22	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.67	8.87	0.00	1.27	1.90	0.00	0.00	0.00	1.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	10.69	5.52	0.69	2.41	1.03	0.69	0.00	0.69	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	8.60	0.00	2.15	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.45	6.52	0.41	0.41	0.00	1.22	0.00	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	12.71	7.15	0.00	2.38	0.79	0.00	0.00	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	13.56	5.90	1.18	1.77	0.00	2.36	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	19.01	7.48	0.94	1.87	0.62	0.31	0.00	0.62	1.87	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	24.06	8.02	0.00	0.00	0.00	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	7.10	0.00	2.37	0.00	2.37	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	8.95	0.69	2.75	0.69	2.07	0.00	0.00	2.75	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	12.86	0.99	0.00	0.00	1.48	0.49	0.00	0.00	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	5.61	0.00	1.12	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.63	2.54	0.64	0.00	1.27	0.64	0.00	0.00	2.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	16.12	4.43	0.00	0.40	0.00	2.01	0.00	0.81	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	2.18	0.00	0.00	0.00	0.00	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	2.53	0.00	1.27	2.53	1.27	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.96	1.21	0.00	0.61	1.21	1.21	0.00	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	0.00	0.00	0.00	9.04	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	10.71	6.59	0.00	0.00	0.82	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.54	5.95	0.60	0.79	0.40	0.79	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.03	5.19	0.00	0.65	0.97	1.62	0.00	0.32	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	11.20	6.11	1.02	3.06	0.00	0.00	0.00	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	37.14	4.64	1.55	0.77	0.00	0.00	0.00	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	1.42	3.54	0.94	0.00	1.65	0.24	0.00	0.24	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	6.02	1.16	0.70	0.00	0.00	0.00	0.00	0.23	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	2.16	0.10	0.00	0.00	0.00	0.00	0.00	0.51	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	2.95	4.09	0.00	0.00	0.00	0.45	0.00	0.23	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	5.13	3.42	0.24	0.24	0.49	0.00	0.00	0.73	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	6.64	3.10	1.77	0.00	0.22	0.22	0.00	0.22	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	0.79	1.84	0.26	0.00	0.26	0.26	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	6.64	3.74	0.34	0.34	0.85	0.85	0.00	1.19	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	6.32	1.52	0.51	0.25	0.00	0.25	0.00	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	7.25	6.21	1.24	1.45	0.62	1.04	0.00	0.41	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	6.13	4.97	0.66	0.17	1.49	0.17	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	4.89	1.09	0.90	0.18	0.18	0.00	0.00	0.00	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	3.93	2.05	0.51	0.34	0.51	0.00	0.00	0.51	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	1.78	0.76	0.25	0.00	0.00	0.00	0.00	0.51	0.00	0.00
mesothelioma cell line:No36	10857-111G2	7.50	2.28	0.98	0.98	0.33	0.00	0.00	0.65	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	3.52	1.63	1.08	0.00	0.54	0.00	0.00	0.27	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	10.36	2.49	1.15	0.58	0.58	0.58	1.34	0.38	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	6.11	3.42	0.37	0.49	1.59	0.37	0.24	0.24	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	6.10	4.31	1.62	0.72	1.44	0.18	1.62	0.36	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	3.59	3.59	0.98	0.98	0.33	0.33	0.00	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	2.12	2.12	0.85	0.21	0.85	0.00	0.00	0.00	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	2.07	1.15	0.46	0.00	0.46	0.00	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	3.23	2.47	0.19	0.00	0.19	1.33	0.00	0.38	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	11.46	9.61	1.11	0.18	0.55	0.55	0.37	0.74	0.55	0.18
myeloma cell line:PCM6	10474-106I6	4.15	1.58	0.99	0.00	0.59	0.79	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	6.59	0.51	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	2.94	0.20	0.20	0.00	0.00	0.20	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	5.46	3.90	0.45	0.33	0.11	0.33	0.00	0.22	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.00	2.28	1.32	0.15	0.29	0.44	0.00	0.22	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	6.07	2.76	1.66	0.00	0.00	0.00	0.00	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	2.76	12.42	0.46	1.38	0.92	0.23	0.00	0.00	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	2.06	4.12	0.19	1.12	0.56	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	3.37	18.35	2.11	2.95	3.80	2.53	0.00	0.00	0.00	0.84
neuroblastoma cell line:NH-12	10555-107I6	3.91	14.35	1.49	4.66	1.86	0.37	0.00	0.00	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	4.98	6.64	0.71	0.47	1.66	0.71	0.00	0.47	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	23.44	20.59	2.38	9.34	2.06	2.69	0.00	0.79	0.32	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	9.46	2.82	0.40	2.01	0.40	0.20	0.00	0.40	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	9.54	1.91	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	28.48	7.19	1.06	1.86	1.86	0.27	0.00	0.80	0.80	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1.01	1.52	0.17	0.17	0.68	0.17	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	4.80	5.60	0.00	0.80	0.80	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	17.63	13.79	1.92	3.85	1.28	1.60	0.00	0.00	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.87	11.56	3.68	2.10	1.84	0.53	0.00	0.79	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	46.21	16.03	3.28	2.06	2.16	1.59	0.19	4.31	0.47	0.37
occipital cortex - adult, donor10196	10172-103C1	39.15	14.42	4.12	0.00	0.00	0.00	0.00	6.18	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	56.62	9.12	2.15	1.07	0.81	1.34	0.27	2.15	0.54	0.27
occipital cortex, newborn, donor10223	10355-105E4	14.19	14.92	1.09	1.82	1.09	0.73	0.00	1.09	1.46	1.09
occipital lobe, adult, donor1	10076-102A4	31.23	15.74	1.84	1.05	2.36	2.10	0.00	1.84	0.00	0.52
occipital lobe, fetal, donor1	10073-102A1	11.59	14.59	0.43	1.72	1.29	0.43	0.00	2.57	0.86	0.00
occipital pole, adult, pool1	10036-101E9	35.64	18.61	2.52	2.13	0.95	1.81	0.00	2.92	0.55	0.16
olfactory region, adult	10195-103E6	41.27	8.60	2.10	0.96	1.15	0.57	0.00	4.59	0.00	0.00
optic nerve, donor1	10277-104E7	304.16	12.01	0.00	4.00	0.00	6.00	0.00	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	11.28	7.18	0.80	0.23	0.46	1.71	0.00	0.34	0.00	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1.37	4.40	0.41	0.27	0.41	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	2.37	2.20	0.34	0.17	0.68	0.00	0.00	0.17	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	0.58	1.85	0.12	0.00	0.35	0.12	0.00	0.00	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	19.40	14.99	0.59	0.88	2.35	1.76	0.00	0.59	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1.87	0.93	0.00	0.93	0.93	0.00	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	19.30	10.60	1.06	2.33	1.27	1.27	0.00	0.64	0.00	0.00
ovary, adult, pool1	10020-101D2	49.44	13.98	3.67	2.88	2.71	2.36	0.26	0.52	1.83	0.87
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	13.38	2.57	1.10	0.18	0.37	0.18	0.00	0.55	0.00	0.00
pancreas, adult, donor1	10049-101G4	140.16	44.21	20.69	50.79	6.58	20.69	0.00	0.00	7.53	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	22.36	20.69	6.15	3.35	4.19	3.63	0.00	0.00	0.84	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	5.96	8.86	1.02	1.53	2.38	0.17	0.00	0.00	0.00	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	6.29	7.45	0.83	0.00	1.32	0.00	0.00	0.17	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	32.86	14.55	3.29	1.10	1.83	2.38	0.27	1.83	0.37	0.18
parietal cortex, adult, donor10258	10373-105G4	32.30	6.61	1.47	1.47	2.20	0.00	0.00	5.14	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	51.73	4.70	1.88	0.94	2.82	0.00	0.00	4.70	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	43.04	9.12	3.14	0.57	1.14	0.29	0.57	2.28	0.57	0.00
parietal lobe, adult, pool1	10034-101E7	43.35	15.86	4.41	1.23	2.29	1.85	0.00	1.76	0.53	0.09
parietal lobe, fetal, donor1	10072-101I9	7.76	12.61	0.00	0.97	1.94	3.88	0.00	2.91	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	11.59	14.58	1.50	0.37	2.24	1.12	0.75	1.87	0.00	1.50
parotid gland, adult	10199-103F1	82.02	14.80	2.47	2.47	5.55	14.80	0.00	1.23	2.47	0.00
penis, adult	10200-103F2	37.60	6.45	3.76	2.15	1.07	1.07	0.00	1.07	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	9.67	6.88	1.12	1.49	0.37	1.12	0.00	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	3.50	6.26	0.44	0.73	1.60	0.15	0.00	0.58	0.15	0.44
pineal gland - adult, donor10196	10179-103C8	50.31	8.39	3.87	0.65	2.58	0.00	0.00	3.23	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	58.04	3.55	1.18	0.59	0.59	0.00	0.00	4.15	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	33.86	8.78	1.88	0.00	1.25	0.63	0.63	5.02	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	58.68	8.09	2.02	4.05	1.01	4.05	0.00	3.04	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	56.29	19.28	4.17	2.61	1.04	0.52	0.00	1.56	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	47.67	11.92	1.70	1.70	2.55	4.26	0.00	4.26	1.70	0.00
placenta, adult, pool1	10021-101D3	25.26	12.69	3.66	1.29	2.37	1.40	0.43	0.43	1.40	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	10.46	2.12	1.06	0.13	1.19	0.40	0.13	0.13	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	6.69	2.49	0.62	0.00	0.62	0.00	0.00	0.31	0.00	0.00
pons, adult, pool1	10033-101E6	47.94	7.14	3.79	1.38	0.95	1.55	0.34	1.29	0.52	0.34
postcentral gyrus, adult, pool1	10032-101E5	37.31	17.87	4.27	1.13	1.22	2.09	0.00	2.88	0.35	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	8.30	4.22	2.62	0.29	1.31	0.15	0.00	0.15	0.00	0.29
prostate cancer cell line:PC-3	10439-106E7	7.08	10.53	1.63	0.18	0.36	0.18	0.00	0.18	0.00	0.18
prostate, adult, pool1	10022-101D4	38.36	8.71	2.27	1.18	1.27	2.54	0.45	0.45	0.54	0.00
putamen, adult, donor10196	10176-103C5	36.12	8.97	3.30	1.65	0.94	0.94	0.24	4.72	0.94	0.00
putamen, adult, donor10252	10152-102I8	23.53	0.00	0.00	0.00	1.96	0.00	0.00	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	5.46	1.09	0.00	1.09	0.00	0.00	0.00	2.19	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	25.37	7.73	2.90	1.21	1.21	0.97	0.00	3.14	0.24	0.24
putamen, newborn, donor10223	10365-105F5	22.49	6.75	1.50	0.75	0.75	1.50	0.00	4.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	4.65	7.27	0.29	0.29	1.16	0.00	0.00	0.00	0.00	0.29
rectum, fetal, donor1	10067-101I4	13.91	2.78	0.00	2.78	1.39	0.00	0.00	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	9.75	0.64	1.27	0.00	0.00	0.21	0.00	0.64	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	11.60	1.24	3.31	0.00	0.83	0.00	0.00	0.83	0.00	0.00
retina, adult, pool1	10030-101E3	45.43	12.52	3.28	2.09	1.69	3.08	0.70	2.19	0.99	0.30
retinoblastoma cell line:Y79	10475-106I7	2.86	10.65	1.56	1.82	1.82	0.26	0.00	0.52	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.57	12.29	4.06	4.55	1.72	0.49	0.00	0.00	0.37	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	3.09	15.75	0.28	6.47	0.84	0.00	0.00	0.00	0.28	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	25.77	5.30	1.52	0.76	3.03	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	7.45	8.25	0.81	0.97	0.97	0.49	0.00	0.00	0.16	0.16
salivary acinar cells, donor2	11772-123I8	14.59	9.78	1.10	1.24	0.83	2.07	0.00	0.41	0.14	0.41
salivary acinar cells, donor3	11773-123I9	37.07	5.30	1.32	0.66	0.00	0.66	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	69.78	8.01	2.86	1.72	0.00	12.58	0.57	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	2.11	4.13	0.67	0.08	0.51	0.17	0.00	0.08	0.00	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	3.29	2.47	0.24	0.24	0.47	0.35	0.00	0.00	0.00	0.00
seminal vesicle, adult	10201-103F3	46.03	14.81	1.59	2.12	2.12	2.12	0.00	0.53	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	8.50	4.13	1.70	1.46	1.21	0.24	0.00	0.00	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	3.52	1.76	1.01	0.25	0.00	0.00	0.00	0.25	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	4.01	2.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	26.33	5.64	2.82	2.01	0.67	0.81	0.00	0.81	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	6.52	6.96	0.77	0.66	0.99	0.44	0.00	0.22	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	9.42	2.97	0.65	0.13	0.00	0.26	0.00	0.52	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	21.28	2.13	0.71	0.71	1.42	0.71	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	14.51	9.48	2.04	1.92	0.72	1.68	0.36	0.00	0.36	0.36
skeletal muscle, fetal, donor1	10066-101I3	27.14	19.10	3.02	7.04	4.02	1.01	0.00	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	47.50	20.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	24.62	8.84	3.79	0.63	1.26	0.63	0.00	0.63	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	0.33	2.67	1.33	0.67	1.00	0.00	0.00	0.00	0.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	9.77	5.67	0.95	1.58	1.58	0.00	0.00	0.32	0.32	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	21.59	3.47	1.35	0.00	0.58	0.39	0.19	2.51	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	1.65	3.63	0.82	0.33	0.16	0.00	0.00	0.00	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	5.15	4.66	0.64	0.97	0.64	0.00	0.00	0.48	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	10.02	12.64	1.53	0.44	2.40	0.87	0.00	0.44	0.44	0.44
small intestine, adult, pool1	10024-101D6	85.64	21.02	3.94	2.63	1.91	19.35	0.12	0.84	18.39	0.12
small intestine, fetal, donor1	10064-101I1	29.97	9.83	1.47	1.72	0.74	1.97	0.00	0.98	6.39	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	6.67	2.05	1.54	0.51	0.00	0.00	0.00	0.51	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	52.72	1.55	1.55	1.29	1.03	3.10	0.78	0.26	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	5.63	0.80	0.54	0.00	0.00	0.27	0.00	0.54	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	123.19	5.74	5.28	0.92	1.15	0.69	0.00	2.98	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	74.52	6.31	1.18	0.79	0.00	0.39	1.97	0.39	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	76.10	1.38	0.69	0.69	0.00	0.69	0.69	1.38	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	30.49	10.37	4.27	3.66	0.61	3.05	0.00	0.61	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	49.59	4.59	1.84	2.30	0.46	0.00	0.00	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	20.61	10.01	2.69	1.79	1.79	0.30	0.00	0.60	0.90	0.30
spleen, adult, pool1	10025-101D7	15.31	9.58	2.53	1.76	2.42	1.21	2.20	0.44	0.33	0.00
spleen, fetal, pool1	10044-101F8	24.00	12.87	3.18	1.75	2.54	1.91	4.45	0.64	0.16	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	21.84	3.93	1.55	0.62	1.14	0.52	1.86	0.83	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	1.33	1.52	0.38	0.00	0.38	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	26.21	8.74	3.84	0.00	0.70	2.80	0.00	0.35	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	17.59	2.74	1.56	0.00	0.39	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	8.55	8.44	1.91	0.11	0.34	0.45	0.00	0.79	0.00	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	0.42	2.96	0.00	0.42	1.27	0.00	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	126.02	5.34	3.20	1.07	4.27	1.07	0.00	0.00	2.14	0.00
submaxillary gland, adult	10202-103F4	45.57	7.98	2.85	1.71	1.71	12.53	0.00	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	65.22	3.12	2.28	0.83	0.83	0.62	0.83	1.25	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	47.07	7.24	3.62	0.00	1.55	0.52	0.00	2.59	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	47.34	9.19	0.71	3.53	1.41	0.00	0.00	1.41	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	8.94	19.72	5.04	2.75	2.75	0.92	0.00	0.23	0.92	0.69
temporal lobe, adult, pool1	10031-101E4	38.06	18.73	4.07	2.37	2.63	1.95	0.08	3.81	0.17	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	4.99	7.83	1.42	0.00	0.71	0.71	0.00	3.56	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	8.35	9.67	1.32	1.76	1.76	0.44	0.00	1.76	0.00	0.00
tenocyte, donor1	11763-123H8	23.74	11.52	1.75	0.70	0.35	0.35	0.00	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	26.71	6.87	1.14	1.53	1.91	0.38	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	17.05	11.49	1.48	0.74	0.37	0.74	0.00	0.74	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	3.57	4.42	0.68	0.17	1.02	0.17	0.00	0.00	0.34	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	4.32	7.09	1.85	3.55	0.62	1.08	0.15	0.00	1.23	0.00
teratocarcinoma cell line:PA-1	10807-111A6	1.24	6.20	0.77	3.25	0.15	0.15	0.00	0.00	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1.52	5.33	0.38	2.29	0.76	0.76	0.00	0.00	0.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1.89	5.29	0.38	0.76	0.38	0.76	0.00	0.76	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	0.65	3.71	0.11	1.64	0.44	0.00	0.00	0.00	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	1.30	1.63	0.98	1.30	0.98	0.33	0.00	0.00	0.33	0.00
testis, adult, pool1	10026-101D8	31.89	16.75	4.19	4.29	2.36	3.33	0.32	1.93	0.75	1.07
testis, adult, pool2	10096-102C6	49.17	17.14	9.92	2.71	3.16	4.06	0.00	2.26	0.00	1.80
thalamus - adult, donor10196	10168-103B6	105.98	5.52	4.42	1.10	1.10	1.10	0.00	2.21	1.10	0.00
thalamus, adult, donor10252	10154-103A1	59.23	2.97	2.66	0.16	1.09	0.47	0.78	1.88	0.31	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	0.00	1.54	1.54	3.08	3.08	3.08	1.54	1.54	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	32.11	4.94	2.47	0.33	1.15	1.15	0.33	2.31	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	16.11	2.88	0.00	0.58	2.88	2.30	0.00	2.30	0.00	0.00
throat, adult	10209-103G2	18.23	6.99	1.00	0.75	2.00	2.50	0.00	1.00	0.75	0.00
throat, fetal, donor1	10061-101H7	17.37	7.31	1.52	1.52	1.83	0.00	0.00	0.30	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	2.38	5.17	0.60	0.99	0.00	0.00	0.00	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	10.14	10.34	1.09	1.39	2.78	1.49	0.40	0.40	0.10	0.10
thymus, fetal, pool1	10043-101F7	22.76	15.07	3.53	1.04	4.68	1.87	0.73	0.31	0.31	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	1.60	2.53	0.80	0.27	0.80	0.00	0.00	0.13	0.00	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	4.33	6.98	0.42	1.54	1.68	0.28	0.00	0.00	0.00	0.28
thyroid, adult, pool1	10028-101E1	28.74	11.29	3.45	2.15	1.49	2.43	0.56	1.21	0.47	0.09
thyroid, fetal, donor1	10060-101H6	31.11	8.70	5.01	3.16	3.43	1.58	0.00	1.05	0.26	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	46.19	6.16	3.08	0.00	0.00	3.08	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	19.30	5.35	2.09	1.16	0.93	1.16	0.00	0.00	0.00	0.00
tongue, fetal, donor1	10059-101H5	11.82	5.12	1.97	0.39	1.18	0.39	0.00	0.39	0.00	0.00
tonsil, adult, pool1	10047-101G2	27.75	10.12	4.01	1.10	3.41	2.40	4.61	1.30	0.20	0.00
trachea, adult, pool1	10029-101E2	14.07	8.83	1.55	2.37	1.55	1.06	0.74	0.33	0.49	0.74
trachea, fetal, donor1	10058-101H4	18.85	6.16	1.92	0.77	0.77	1.15	0.00	0.38	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.27	8.86	0.71	1.77	2.13	0.71	0.00	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	2.33	3.44	0.20	0.51	0.10	0.00	0.00	0.00	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	2.98	9.09	0.47	0.94	0.78	0.94	0.00	0.00	0.16	0.16
tridermal teratoma cell line:HGRT	10694-109G1	15.22	1.90	1.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	3.89	9.06	0.42	1.52	0.93	0.59	0.00	0.17	0.08	0.08
umbilical cord, fetal, donor1	10057-101H3	18.78	6.26	2.09	0.00	4.17	0.00	0.00	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	58.53	14.50	2.39	2.39	3.07	1.19	0.85	1.19	0.68	0.17
uterus, fetal, donor1	10055-101H1	14.33	11.26	1.02	5.63	2.05	1.02	0.00	0.51	0.51	0.00
vagina, adult	10204-103F6	19.39	1.94	0.00	0.65	1.29	0.00	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	39.46	10.08	2.19	1.53	1.32	2.85	3.29	0.44	0.88	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	14.15	5.87	1.87	0.80	0.53	0.27	0.27	0.53	0.00	0.27